Special Article

Is the Placebo Powerless? — An Analysis of Clinical Trials Comparing Placebo with No Treatment

Asbjørn Hróbjartsson, M.D., and Peter C. Gøtzsche, M.D.

N Engl J Med 2001; 344:1594-1602May 24, 2001DOI: 10.1056/NEJM200105243442106

Abstract

Background

Placebo treatments have been reported to help patients with many diseases, but the quality of the evidence supporting this finding has not been rigorously evaluated.

Methods

We conducted a systematic review of clinical trials in which patients were randomly assigned to either placebo or no treatment. A placebo could be pharmacologic (e.g., a tablet), physical (e.g., a manipulation), or psychological (e.g., a conversation).

Results

We identified 130 trials that met our inclusion criteria. After the exclusion of 16 trials without relevant data on outcomes, there were 32 with binary outcomes (involving 3795 patients, with a median of 51 patients per trial) and 82 with continuous outcomes (involving 4730 patients, with a median of 27 patients per trial). As compared with no treatment, placebo had no significant effect on binary outcomes, regardless of whether these outcomes were subjective or objective. For the trials with continuous outcomes, placebo had a beneficial effect, but the effect decreased with increasing sample size, indicating a possible bias related to the effects of small trials. The pooled standardized mean difference was significant for the trials with subjective outcomes but not for those with objective outcomes. In 27 trials involving the treatment of pain, placebo had a beneficial effect, as indicated by a reduction in the intensity of pain of 6.5 mm on a 100-mm visual-analogue scale.

Conclusions

We found little evidence in general that placebos had powerful clinical effects. Although placebos had no significant effects on objective or binary outcomes, they had possible small benefits in studies with continuous subjective outcomes and for the treatment of pain. Outside the setting of clinical trials, there is no justification for the use of placebos.

Media in This Article

Table 1Effect of Placebo in Trials with Binary or Continuous Outcomes.
Table 2Effect of Placebo on Specific Clinical Problems.
Article

Placebos have been reported to improve subjective and objective outcomes in up to 30 to 40 percent of patients with a wide range of clinical conditions, such as pain, asthma, high blood pressure, and even myocardial infarction.1-3 In his 1955 article “The Powerful Placebo,” Beecher concluded, “It is evident that placebos have a high degree of therapeutic effectiveness in treating subjective responses, decided improvement, interpreted under the unknowns technique as a real therapeutic effect, being produced in 35.2±2.2% of cases.”1

Beecher's article and the 35 percent figure are often cited as evidence that a placebo can be an important medical treatment. The vast majority of reports on placebos, including Beecher's article, have estimated the effect of placebo as the difference from base line in the condition of patients in the placebo group of a randomized trial after treatment. With this approach, the effect of placebo cannot be distinguished from the natural course of the disease, regression to the mean, and the effects of other factors.4-6 The reported large effects of placebo could therefore, at least in part, be artifacts of inadequate research methods.

Despite the reservations of many physicians,7 the clinical use of placebo has been advocated in editorials and articles in leading journals.3,8,9 To understand better the effects of placebo as a treatment, we conducted a systematic review of clinical trials in which patients with various clinical conditions were randomly assigned to placebo or to no treatment. We were primarily interested in the clinical effect of placebo as a treatment for disease, rather than the role of placebo as a comparison treatment in clinical trials. A secondary aim was to study whether the effect of placebo differed for subjective and objective outcomes.

Methods

Definition of Placebo

Placebo is difficult to define satisfactorily.5 In clinical trials, placebos are generally control treatments with a similar appearance to the study treatments but without their specific activity. We therefore defined placebo practically as an intervention labeled as such in the report of a clinical trial.

We searched Medline, EMBASE, PsycLIT, Biological Abstracts, and the Cochrane Controlled Trials Register for trials published before the end of 1998. The search was developed iteratively for synonyms of “placebo,” “no treatment,” and “randomized clinical trial” (the exact search strategy is available as Supplementary Appendix 1 with the full text of this article at http://www.nejm.org and was based on a published protocol10). We systematically read the reference lists of included trials and selected books and review articles. We also asked researchers in the field to provide lists of relevant trials.

Selection of Studies

We included studies if patients were assigned randomly to a placebo group or an untreated group (often there was also a third group that received active treatment). We excluded studies if randomization was clearly not concealed — that is, if group assignment were predictable11 (e.g., patients were assigned to treatment groups according to the day of the month). We also excluded studies if participants were paid or were healthy volunteers, if the person who assessed objective outcomes was aware of group assignments, if the dropout rate exceeded 50 percent, or if it was very likely that the alleged placebo had a clinical effect not associated with the treatment ritual alone (e.g., movement techniques for postoperative pain). All potentially eligible trial reports were read in full by both authors. Disagreements concerning eligibility were resolved by discussion.

Extraction of Data

Data were extracted from the report of each trial with the use of forms tested in pilot studies. We contacted the authors of the included studies when reported outcome data were inadequate for meta-analysis. We noted how the randomization was conducted and whether the therapist responsible for the administration of placebo (as distinct from the observer) was unaware of group assignments. Furthermore, we noted the purpose of the trial, the dropout rate, whether the placebo was given in addition to the standard treatment, and whether the main outcome was clearly indicated.

We noted whether the placebo was pharmacologic (e.g., a tablet), physical (e.g., a manipulation), or psychological (e.g., a conversation); whether clinical problems reported by the patients could have been observed by others (i.e., whether the symptoms were observable outcomes such as cough); and whether objective outcomes were laboratory data, were derived from examinations that required the cooperation of the patients (i.e., objective outcomes such as forced expiratory volume), or did not require such cooperation (e.g., edema).

Both reviewers independently selected outcomes by referring only to the methods sections of articles; any disagreements were resolved by discussion. As the primary outcome, we selected the main objective or subjective outcome of each trial (preferably a characteristic symptom). If a main outcome was not indicated, we used the outcome that we felt was most relevant to patients. Binary outcomes (e.g., the proportions of smokers and nonsmokers) were preferred to continuous ones (e.g., the mean number of cigarettes smoked). Data recorded immediately after the end of treatment were preferred to follow-up data, although end-of-treatment data were not always available. For crossover trials, we extracted data from the first treatment period only; if that was not possible, we used the summary data as if they had been derived from a parallel-group trial (i.e., using the between-group standard deviations and total number of participants for both groups).

Synthesis of Data

For each trial with binary outcomes, we calculated the relative risk of an unwanted outcome, defined as the ratio of the number of patients with an unwanted outcome to the total number of patients in the placebo group, divided by the same ratio in the untreated group. Thus, a relative risk below 1.0 indicates a beneficial effect of placebo.

For trials with continuous outcomes, we calculated the standardized mean difference, which was defined as the difference between the mean value for an unwanted outcome in the placebo group and the corresponding mean value in the untreated group divided by the pooled standard deviation.12 A value of –1 signifies that the mean in the placebo group was 1 SD below the mean in the untreated group, indicating a beneficial effect of placebo.

We calculated the pooled relative risk of an unwanted outcome for trials with binary outcomes and the pooled standardized mean difference for those with continuous outcomes.13 Because of the different clinical conditions and settings, we expected that the data sets would be heterogeneous — that is, that the effects of individual trials would vary more than expected by chance alone. The variance and statistical significance of the differences were therefore assessed with the use of random-effect calculations.13 We calculated the pooled effects for subjective and objective outcomes and for specific clinical problems that had been investigated in at least three trials by different research groups.14

We performed preplanned analyses of subgroups to see whether our findings were sensitive to the type of placebo or the type of outcome involved. Furthermore, for each trial, we plotted the effect against the inverse of its standard error (which increases with the number of trial participants). Since the variation in the estimated effect decreases with increasing sample size, the plot is expected to resemble a symmetrical funnel. If there is significant asymmetry in such funnel plots, it is usually caused by small trials' reporting greater effects, on average, than large trials, which can reflect publication bias15 or other biases. We also performed several preplanned sensitivity analyses to determine whether our findings were sensitive to variations in the quality of the trials.

In trials with continuous outcomes, we used F tests to check whether the standard deviations of the placebo group and the untreated group were significantly different.16 We regarded the distributions of either group as non-Gaussian if 1.64 SD exceeded the mean for positive outcomes.17 Chi-square tests were used to test for heterogeneity on the basis of the DerSimonian and Laird Q statistic.13,18 Results are reported with 95 percent confidence intervals. All P values are two-tailed.

Results

Selection and Characteristics of Studies

We identified 727 potentially eligible trials. We subsequently excluded 597 trials for the following reasons: 404 were nonclinical or nonrandomized, 129 were missing a placebo group or an untreated group, 29 were reported in more than one publication, 11 had clearly unblinded assessment of objective outcomes, and 24 met other criteria for exclusion, such as dropout rates over 50 percent. No relevant outcome data were available for 16 of the remaining 130 trials. The analysis therefore included 114 trials.19-132

There were 10 crossover trials, of which 7 (which included a total of 182 patients) were handled as parallel trials. In 112 trials, there was a third group assigned to active treatment in addition to the placebo and the untreated groups. In 88 of these, determining the effect of placebo was not mentioned as an objective of the study. The trial reports were published in five languages between 1946 and 1998. The outcomes were binary in 32 trials19-50 and continuous in 82.51-132 In 76 trials, the outcome in the data we extracted was identified as a main outcome by the authors of the trials. If only patients in the placebo and untreated groups were counted, the trials with binary outcomes included 3795 patients with a median of 51 patients per trial (interquartile range, 26 to 72), and the trials with continuous outcomes included 4730 patients with a median of 27 patients per trial (interquartile range, 20 to 52).

The typical pharmacologic placebo was a lactose tablet. The typical physical placebo was a procedure performed with a machine that was turned off (e.g., sham transcutaneous electrical nerve stimulation). The typical psychological placebo was a nondirectional, neutral discussion between the patient and the treatment provider, referred to as an “attention placebo.” No treatment typically entailed observation only or standard therapy; in the latter case, all patients in the trial received standard therapy, and the placebo was additional.

The results for the individual trials are available as Supplementary Appendix 2Supplementary Appendix 2. Trials with Binary Outcomes. and Supplementary Appendix 3Supplementary Appendix 3. Trials with Continuous Outcomes. with the full text of this article at http://www.nejm.org. The trials investigated 40 clinical conditions: hypertension, asthma, anemia, hyperglycemia, hypercholesterolemia, seasickness, Raynaud's disease, alcohol abuse, smoking, obesity, poor oral hygiene, herpes simplex infection, bacterial infection, common cold, pain, nausea, ileus, infertility, cervical dilatation, labor, menopause, prostatism, depression, schizophrenia, insomnia, anxiety, phobia, compulsive nail biting, mental handicap, marital discord, stress related to dental treatment, orgasmic difficulties, fecal soiling, enuresis, epilepsy, Parkinson's disease, Alzheimer's disease, attention-deficit–hyperactivity disorder, carpal tunnel syndrome, and undiagnosed ailments.

Binary Outcomes

As compared with no treatment, placebo did not have a significant effect on binary outcomes (overall pooled relative risk of an unwanted outcome with placebo, 0.95; 95 percent confidence interval, 0.88 to 1.02). The pooled relative risk was 0.95 for trials with subjective outcomes (95 percent confidence interval, 0.86 to 1.05) and 0.91 for trials with objective outcomes (95 percent confidence interval, 0.80 to 1.04) (Table 1Table 1Effect of Placebo in Trials with Binary or Continuous Outcomes.).

There was significant heterogeneity among the trials with binary outcomes (P=0.003), indicating that the variation in the effect of placebo among trials was larger than would be expected to result from chance alone. The heterogeneity was not due to small trials' showing more pronounced effects of placebo than large trials (P=0.56).15

Three clinical problems had been investigated in at least three independent trials with binary outcomes: nausea, relapse after the cessation of smoking, and depression. Placebo had no significant effect on these outcomes, but the confidence intervals were wide (Table 2Table 2Effect of Placebo on Specific Clinical Problems.).

Continuous Outcomes

The overall pooled standardized mean difference was –0.28 (95 percent confidence interval, –0.38 to –0.19). Thus, there was a beneficial effect of placebo, because the pooled mean of the placebo groups was 0.28 SD lower than the pooled mean of the untreated groups (P<0.001). The pooled standardized mean difference was significant for trials with subjective outcomes (–0.36; 95 percent confidence interval, –0.47 to –0.25) but not for trials with objective outcomes (–0.12; 95 percent confidence interval, –0.27 to 0.03) (Table 1).

There was significant heterogeneity among the trials with continuous outcomes (P<0.001). The magnitude of the effect of placebo decreased with increasing sample size (P=0.05), indicating a possible bias related to the effects of small trials.

Pain, obesity, asthma, hypertension, insomnia, and anxiety were each investigated in at least three independent trials. Only the 27 trials involving the treatment of pain (including a total of 1602 patients) showed a significant effect of placebo as compared with no treatment (pooled standardized mean difference, –0.27; 95 percent confidence interval, –0.40 to –0.15). There was no significant effect of placebo on the other conditions, although the confidence intervals were wide (Table 2).

Expressing the standardized mean differences in terms of clinical outcomes indicates that the effect of placebo on pain corresponds to a reduction in the mean intensity of pain of 6.5 mm (95 percent confidence interval, 3.6 to 9.6) on a 100-mm visual-analogue scale. The nonsignificant effect of placebo on obesity corresponds to a reduction in mean weight of 3.2 percent (95 percent confidence interval, 7.4 to –1.2 percent); on hypertension, a reduction in mean diastolic blood pressure of 3.2 mm Hg (95 percent confidence interval, 7.8 to –1.3); and on insomnia, a decrease in the mean time required to fall asleep of 10 minutes (95 percent confidence interval, 25 to –5). For asthma and anxiety, the measurement scales were too variable to allow clinical interpretation of the results.

Small trials involving the treatment of pain did not have significantly greater effects than large trials (P=0.20), but the power of the test was low.15 There was no significant heterogeneity among the nine sets of data on specific clinical problems (P>0.10), but the power of these analyses was also low.

Sensitivity Analyses

The number of trials compared in the sensitivity analyses was in most cases nine or more, and they included more than 1000 patients. There was no difference in the effect of placebo between subcategories of objective and subjective binary outcomes (Table 3Table 3Effect of Placebo in Trials with Specific Types of Outcomes.). The effect of placebo among subcategories of continuous outcomes did not differ significantly, except for a negative effect of placebo in four trials with laboratory data66,67,75,76 (Table 3). For both continuous and binary outcomes, there were no significant differences among the various types of placebos (Table 4Table 4Effect of Three Types of Placebo.).

The effect of placebo on continuous or binary outcomes was not influenced by the dropout rate (≤ 15 percent vs. > 15 percent) or by whether the observers were aware of group assignments, but only two trials with binary objective outcomes (involving 316 patients) included observers who were clearly unaware of the group assignments39,40 (data not shown). The effects of placebo were also unrelated to whether the care providers were unaware of the treatment type (placebo or experimental), whether placebos were given in addition to standard treatments, whether the effect of placebo was an explicit research objective, or whether we had identified the main outcome on the basis of clinical relevance (data not shown). The size of the effect in trials with clearly concealed randomization did not differ from that in other trials, but only four trials with continuous outcomes84,95,97,107 (involving 523 patients) and one with binary outcomes40 (involving 54 patients) reported clearly concealed randomization (data not shown). For continuous outcomes, the effect was not influenced by non-Gaussian distributions in the placebo or the untreated groups (data not shown).

Discussion

We did not detect a significant effect of placebo as compared with no treatment in pooled data from trials with subjective or objective binary or continuous objective outcomes. We did, however, find a significant difference between placebo and no treatment in trials with continuous subjective outcomes and in trials involving the treatment of pain.

Several types of bias may have affected our findings. Blinded evaluation of subjective outcomes was not possible in the trials we reviewed. Patients in an untreated group would know they were not being treated, and patients in a placebo group would think they had received treatment. It is difficult to distinguish between reporting bias and a true effect of placebo on subjective outcomes, since a patient may tend to try to please the investigator and report improvement when none has occurred. The fact that placebos had no significant effect on objective continuous outcomes suggests that reporting bias may have been a factor in the trials with subjective outcomes.

If patients in the untreated groups sought treatment outside the trials more often than patients in the placebo groups, the effects of placebo might be less apparent. Very few trials provided information on concomitant treatment. The risk of bias is expected to be larger in trials in which placebo is the only treatment and is not given in addition to standard therapy. We did not, however, find a difference in effect between the two types of trials.

There was some evidence that placebos had greater effects in small trials with continuous outcomes than in large trials. This could indicate that some small trials with negative outcomes have not been published or that we did not identify them.15 It is difficult to identify relevant trials in this field; another systematic search for trials involving placebo groups versus untreated groups found only 12 studies.133 We identified 114 trials from which the outcomes could be extracted, but 88 of these trials investigated the effect of active treatment in a third group of patients and did not explicitly study the effect of placebo. Because the publication of such trials is not directly associated with the effect of placebo, it is unlikely that the existence of unpublished trials could explain the higher effects reported in small studies.

Poor methodology in small trials could also explain the large effects of placebo. It surprised us that we found no association between measures of the quality of a trial and placebo effects. However, the statistical power of our sensitivity analyses may have been too low. Furthermore, it is possible that small trials tended to investigate clinical conditions in which placebos truly had greater effects. Thus, although we found an effect of placebos on subjective continuous outcomes, the inverse relation between trial size and effect size implies that the estimates of pooled effect should be interpreted cautiously.

It can also be difficult to interpret whether a pooled standardized mean difference is large enough to be clinically meaningful. Some individual trials reported clinically relevant effects with standardized mean differences of less than –0.6,91 but such “outlier” values may be spurious. If the possible biases we have discussed are disregarded, the pooled effect of placebo on pain corresponds to one third of the effect of nonsteroidal antiinflammatory drugs, as compared with placebo, in double-blind trials.134 It is uncertain whether such an effect is important for patients.

Our study has other limitations. We did extensive analyses of predefined subgroups according to the type of placebo, disease, and outcome without identifying a subgroup of trials in which the effect of placebo was large. However, we cannot exclude the possibility that, in the pooling of heterogeneous trials, the existence of such a subgroup was obscured. Our conclusions are also limited to the clinical conditions and outcomes that were investigated. It should be noted that few trials reported on the quality of life or patients' well-being.

We reviewed the effect of placebos but not the effect of the patient–provider relationship. We could not rule out a psychological therapeutic effect of this relationship, which may be largely independent of any placebo intervention.20

Moreover, the use of placebos in blinded, randomized trials is a precaution directed against many forms of bias and not only a way of controlling for the effects of placebo. Patients who are aware of their treatment assignment may differ from unaware patients in their way of reporting beneficial and harmful effects of treatment, in their tendency to seek additional treatment outside the study, and in their risk of dropping out of the study. Furthermore, staff members who are aware of treatment assignments may differ in their use of alternative forms of care and in their assessment of outcomes. Thus, even if there was no true effect of placebo, one would expect to find differences between placebo and untreated groups because of bias associated with a lack of double-blinding.

We were unable to detect any such significant difference in trials with subjective or objective binary or continuous objective outcomes. This surprising finding can possibly be explained by our selection of trials. Since our goal was to study the clinical effect of placebos, we reduced the influence of observer bias and bias due to dropouts by excluding trials with clearly unblinded objective outcomes and by attempting to analyze post-treatment data instead of follow-up data. In addition, since most trials we included did not primarily address the effect of a placebo but, rather, evaluated that of an active treatment, our study may have underestimated bias associated with the interests of the investigators. Since the design of our review precludes estimation of the overall influence of bias due to a lack of double-blinding, our results do not imply that control groups that receive no treatment can be substituted for control groups that receive placebo without creating a risk of bias. This result is in accordance with an empirical study of 33 meta-analyses, which found that randomized trials that were not double-blinded yielded larger estimates than blinded trials, with odds ratios that were exaggerated by 17 percent.11

In conclusion, we found little evidence that placebos in general have powerful clinical effects. Placebos had no significant pooled effect on subjective or objective binary or continuous objective outcomes. We found significant effects of placebo on continuous subjective outcomes and for the treatment of pain but also bias related to larger effects in small trials. The use of placebo outside the aegis of a controlled, properly designed clinical trial cannot be recommended.

Supported by a grant from the Faculty of Health Sciences at the University of Copenhagen.

We are indebted to Henrik R. Wulff, Jos Kleijnen, and Iain Chalmers for valuable comments on previous versions of the manuscript; to Gunvor Kienle, Andrew Vickers, Harald Walach, Clive Adams, and Iain Chalmers for lists of relevant trials; and to the numerous placebo-trial researchers for access to additional data.

Source Information

From the Department of Medical Philosophy and Clinical Theory, University of Copenhagen, Panum Institute, and the Nordic Cochrane Centre, Rigshospitalet — both in Copenhagen, Denmark.

Address reprint requests to Dr. Hróbjartsson at the Department of Medical Philosophy and Clinical Theory, University of Copenhagen, Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark, or at .

Appendix

Supplementary Appendix 1. Search Strategy

Medline, EMBASE, PsycLIT, Biological Abstracts, and the Cochrane Controlled Trials Register were searched.

Search history for Medline Advanced SilverPlatter version, from 1966 to 1998

PLACEBO* for MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or ATTENTION* CONTROL* or PSEUDO* TREAT* or UN?SPECIFIC* or NON?SPECIFIC*

and

NO??TREAT* or NO TREAT* or NON TREAT* or UN?TREAT* or UN TREAT* or MINIM* TREAT* or USUAL?TREAT* or USUAL TREAT* or

NO INTERV* or NON INTERV* or NO??INTERV* or NO CONTACT* OR NON CONTACT* or NO??CONTACT?* or USUAL CONTACT* OR USUAL CARE* or

NO PILL* or NON PILL* or NO??PILL* or NO TABLET* or NON TABLET* or NO??TABLET* or NO MEDIC* or NON MEDIC* or NO??MEDIC* or UN MEDIC* or UN?MEDIC* or MINIM* MEDIC* or

NO??SURGER* or NO OPERAT* or NON OPERAT* or NO??OPERAT* OR NO SURGER* OR NON SURGER* OR NO??SURGER* or

(NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in AB or (NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in T1

WAITING LIST* or WAITING?LIST* or ((NATURAL or SPONTANEOUS) NEAR1 (COURSE or DEVELOPMENT or HISTORY)) or

((TWO or “2” or THREE or “3” or FOUR or “4” or FIVE or “5” or SIX or “6” or SEVEN or “7”) NEAR1 (GROUPS or TREATMENT GROUPS)) NEAR (CONTROL or CONTROLS)

and

DOUBLE-BLIND-METHOD or SINGLE-BLIND-METHOD or RANDOM-ALLOCATION or RANDOMIZED-CONTROLLED-TRIALS/ALL SUBHEADINGS or CLINICAL-TRIALS/ALL SUBHEADINGS or

(CLINICAL-TRIAL or RANDOMIZED-CONTROLLED-TRIAL or CONTROLLED-CLINICAL-TRIAL) in PT or

RANDOM* or (CLINICAL near TRIAL*) or DOUBLE* BLIND* or SINGLE* BLIND*

and

HUMAN in TG

Comment:

The central search term “no” was initially an unsearchable stop word in Medline. With the help of the staff at Radcliffe Science Library in Oxford in the United Kingdom, we contacted the National Library of Medicine in the United States and the status of “no” was changed to that of a normal search word.

Search strategy for EMBASE CD SilverPlatter version, from 1980 to 1998

PLACEBO* or MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or ATTENTION* CONTROL* or PSEUDO* TREAT* OR UN?specific* or NON?SPECIFIC*

and

NO??TREAT* or NO TREAT* or NON TREAT* or UN?TREAT* or UN TREAT* or MINIM* TREAT* or USUAL?TREAT* or USUAL TREAT* or WITHOUT TREAT* or WITHOUT?TREAT* or

NO INTERV* or NON INTERV* or NO??INTERV* or NO CONTACT* OR NON CONTACT* or NO??CONTACT* or USUAL CONTACT*or USUAL CARE* or

(NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in AB or (NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in T1 or

NO PILL* or NON PILL* or NO??PILL* or NO TABLET* or NON TABLET* or NO??TABLET* or

WAITING LIST* or WAITING?LIST* or ((NATURAL or SPONTANEOUS) NEAR1 (COURSE or DEVELOPMENT or HISTORY)) or

NO MEDIC* or NON MEDIC* or NO??MEDIC* or UN MEDIC* or UN?MEDIC* or MINIM* MEDIC* or

NO OPERAT* or NON OPERAT* or NO??OPERAT* or NO SURGER* or NON SURGER* or NO??SURGER* or

((TWO or “2” or THREE or “3” or FOUR or “4” or FIVE or “5” or SIX or “6” or SEVEN or “7”) NEAR1 (GROUPS or TREATMENT GROUPS)) NEAR (CONTROL or CONTROLS)

and

CLINICAL-TRIAL or RANDOMIZED-CONTROLLED-TRIAL or RANDOMIZATION or DOUBLE-BLIND-PROCEDURE or SINGLE-BLIND-PROCEDURE or CONTROLLED-STUDY or MAJOR-CLINICAL-STUDY or CLINICAL-ARTICLE or

RANDOM* or (CLINICAL near TRIAL*) or DOUBLE* BLIND* or SINGLE* BLIND*

and

HUMAN- in DE

Search Strategy for PsycLIT SilverPlatter version up to 1998

PLACEBO* or MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or PSEUDO* TREAT* or ATTENTION* CONTROL* OR UNSPECIFIC* OR NON?SPECIFIC*

and

NO??TREAT* or NO TREAT* or NON TREAT* or UN?TREAT* or UN TREAT* or MINIM* TREAT* or WITHOUT TREAT* or

NO??INTERV* or NO INTERV* OR NON INTERV* or UN?INTERV* or UN INTERV* or MINIM* INTERV* or WITHOUT INTERV* or

NO??MEDIC* or NO MEDIC* or NON MEDIC* or UN?MEDIC* or UN MEDIC* or MINIM* MEDIC* or WITHOUT MEDIC* or NO??PILL* or NO PILL* or NON PILL* or

NO??OPERAT* or NO OPERAT* or NON OPERAT* or UN?OPERAT* or UN OPERAT* or MINIM* OPERAT* or WITHOUT OPERAT* or NO??SURGER* or NO SURGER* or NON SURGER* or MINIM* SURGER* or WITHOUT SURGER* or

WAITING?LIST* or WAITING LIST or VISITATION* or ((NATURAL or SPONTANEOUS) NEAR1 (COURSE* or DEVELOPMENT* or HISTORY*)) or

((TWO or “2” or THREE or “3” or FOUR or “4” or FIVE or “5” or SIX or “6” or SEVEN or “7”) NEAR1 (GROUPS or TREATMENT GROUPS)) NEAR (CONTROL or CONTROLS)

and

not ANIMAL in (PO or DE)

Comment:

Neither the indexation of clinical trials nor the reporting in abstracts in PsycLIT was helpful for the reliable identification of randomized trials. With the purpose of minimizing the number of missed randomized trials, any search terms aimed at identifying clinical trials were omitted. In a later filtering process, abstracts were read in full.

Search strategy for Biological Abstracts on CD SilverPlatter version, from 1986 to 1998

PLACEBO* or MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or ATTENTION* CONTROL* or PSEUDO* CONTROL* or UN?SPECIFIC* or NON?SPECIFIC*

and

NO??TREAT* or NO TREAT* or NON TREAT* or UN?TREAT* or UN TREAT* or MINIM* TREAT* or USUAL?TREAT* or USUAL TREAT* or WITHOUT TREAT* or WITHOUT?TREAT* or

NO INTERV* or NON INTERV* or NO??INTERV* or NO CONTACT* or NON CONTACT* or NO??CONTACT?* or

NO CONTACT* or NON CONTACT* or NO??CONTACT* or USUAL CONTACT* or USUAL CARE* or

NO PILL* or NON PILL* or NO??PILL or NO TABLET* or NON TABLET* or NO??TABLET* or

(NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in TI or

(NO THERAP* or NO??THERAP* or NON THERAP* or MINIM* THERAP* or USUAL* THERAP*) in AB or

NO MEDIC* or NON MEDIC* or NO??MEDIC* or UN MEDIC* or UN?MEDIC* or MINIM* MEDIC* or

NO OPERAT* or NON OPERAT* or NO??OPERAT* or NO SURGER* or NON SURGER* or NO??SURGER* or

WAITING LIST* or WAITING?LIST* or ((NATURAL or SPONTANEOUS) NEAR1 (COURSE or DEVELOPMENT or HISTORY)) or

((TWO or “2” or THREE or “3” or FOUR or “4” or FIVE or “5” or SIX or “6” or SEVEN or “7”) NEAR1 (GROUPS or TREATMENT GROUPS)) NEAR (CONTROL or CONTROLS)

and

RANDOM* or (CLINICAL near TRIAL*) or DOUBLE* BLIND* or SINGLE* BLIND*

and

HUMAN- in OR or HUMAN in DE or HUMANS in ST

Search Strategy for Cochrane Controlled Trials Register version 1998/3

PLACEBO* or MOCK* or SHAM* or FAKE* or VEHICLE* or DUMM* or ATTENTION*CONTROL* or PSEUDO*TREAT* or UN?SPECIFIC* or NON?SPECIFIC*

and

not (MEDLINE or EMBASE)

References were downloaded to a ProCite file. A second search was conducted in ProCite with a simplified search strategy based on “no treatment” expressions:

“no treat*” or “no-treat*” or “non treat*” or “non-treat*” or “untreat*” or “no interv*” or “no-interv*” or “non interv*” or “non-interv*” or “no contact*” or “no-contact*” or “non contact*” or “non-contact*” or “usual care*” or “no tablet*” or “no-tablet*” or “non tablet*” or “non-tablet*” or “no pill*” or “no-pill*” or “non pill*” or “non-pill*” or “waiting list*” or “waitinglist*” or “waiting-list*” or “natural course” or “natural development” or “natural history” or “spontaneous course” or “spontaneous development” or “spontaneous history” or “no medic*” or “non medic*” or “non-medic*” or “no surger” or “non surger*” or “non-surger*” or “no operat*” or “non operat*” or “non-operat*”

Comment:

It was not possible to search for words containing less than three letters in the Cochrane Controlled Trials Register. This made searches for the essential term “no” impossible. The two-phase search strategy described above was therefore implemented.

References

References

  1. 1

    Beecher HK. The powerful placebo. JAMA 1955;159:1602-1606
    CrossRef | Web of Science | Medline

  2. 2

    Lasagna L. The placebo effect. J Allergy Clin Immunol 1986;78:161-165
    CrossRef | Web of Science | Medline

  3. 3

    Brown WA. The placebo effect. Sci Am 1998;278:90-95
    CrossRef | Web of Science | Medline

  4. 4

    Kienle GS, Kiene H. The powerful placebo effect: fact or fiction? J Clin Epidemiol 1997;50:1311-1318
    CrossRef | Web of Science | Medline

  5. 5

    Gotzsche PC. Is there logic in the placebo? Lancet 1994;344:925-926
    CrossRef | Web of Science | Medline

  6. 6

    Hrobjartsson A. The uncontrollable placebo effect. Eur J Clin Pharmacol 1996;50:345-348
    CrossRef | Web of Science | Medline

  7. 7

    Rawlinson MC. Truth-telling and paternalism in the clinic: philosophical reflections on the use of placebos in medical practice. In: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research, and mechanisms. New York: Guilford Press, 1985:403-18.

  8. 8

    Oh VMS. The placebo effect: can we use it better? BMJ 1994;309:69-70
    CrossRef | Web of Science | Medline

  9. 9

    Chaput de Saintonge DM, Herxheimer A. Harnessing placebo effects in health care. Lancet 1994;344:995-998
    CrossRef | Web of Science | Medline

  10. 10

    Hróbjartsson A, Gøtzsche PC. Placebo intervention compared with no treatment (protocol for a Cochrane review). In: The Cochrane library. No. 1. Oxford, England: Update Software, 1999 (software).

  11. 11

    Schulz KF, Chalmers I, Hayes R, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
    CrossRef | Web of Science | Medline

  12. 12

    Estimation of a single effect size: parametric and nonparametric methods. In: Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando, Fla.: Academic Press, 1985:75-106.

  13. 13

    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188
    CrossRef | Medline

  14. 14

    Linde K, Clausius N, Ramirez G, et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997;350:834-843[Erratum, Lancet 1998;351:220.]
    CrossRef | Web of Science | Medline

  15. 15

    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634
    CrossRef | Web of Science | Medline

  16. 16

    Comparing groups — continuous data. In: Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991:179-228.

  17. 17

    Cochrane Consumers & Communication Group. Statistical policy. In: The Cochrane library. No. 1. Oxford, England: Update Software, 1999 (software).

  18. 18

    Comparing groups — categorical data. In: Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991:229-76.

  19. 19

    Tyler DB. The influence of a placebo, body position and medication on motion sickness. Am J Physiol 1946;146:458-466
    Web of Science | Medline

  20. 20

    Thomas KB. General practice consultations: is there any point in being positive? BMJ 1987;294:1200-1202
    CrossRef | Web of Science | Medline

  21. 21

    Hutton N, Wilson MH, Mellits D, et al. Effectiveness of an antihistamine-decongestant combination for young children with the common cold: a randomized, controlled clinical trial. J Pediatr 1991;118:125-130
    CrossRef | Web of Science | Medline

  22. 22

    Guglielmi RS, Roberts AH, Patterson R. Skin temperature biofeedback for Raynaud's disease: a double-blind study. Biofeedback Self Regul 1982;7:99-120
    CrossRef | Medline

  23. 23

    Watzl H, Olbrich R, Rist F, Cohen R. Placebo-Injektionen und Alkoholkontrollen in der stationären Behandlung alkoholkranker Frauen -- eine experimentelle Untersuchung Zweier Behandlungsmerkmale. Z Klin Psychol 1986;15:333-345

  24. 24

    Wilson A, Davidson WJ, Blanchard R. Disulfiram implantation: a trial using placebo implants and two types of controls. J Stud Alcohol 1980;41:429-436
    Web of Science | Medline

  25. 25

    Killen JD, Fortmann SP, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 1990;58:85-92
    CrossRef | Web of Science | Medline

  26. 26

    Malcolm RE, Sillett RW, Turner JAM, Ball KP. The use of nicotine chewing gum as an aid to stopping smoking. Psychopharmacology (Berl) 1980;70:295-296
    CrossRef | Web of Science | Medline

  27. 27

    Jacobs MA, Spilken AZ, Norman MM, Wohlberg GW, Knapp PH. Interaction of personality and treatment conditions associated with success in a smoking control program. Psychosom Med 1971;33:545-556
    Web of Science | Medline

  28. 28

    Williams JM, Hall DW. Use of single session hypnosis for smoking cessation. Addict Behav 1988;13:205-208
    CrossRef | Web of Science | Medline

  29. 29

    Hyman GJ, Stanley RO, Burrows GD, Horne DJ. Treatment effectiveness of hypnosis and behaviour therapy in smoking cessation: a methodological refinement. Addict Behav 1986;11:355-365
    CrossRef | Web of Science | Medline

  30. 30

    Elliott CH, Denney DR. A multiple-component treatment approach to smoking reduction. J Consult Clin Psychol 1978;46:1330-1339
    CrossRef | Web of Science | Medline

  31. 31

    Faas A, Chavannes AW, van Eijk JTM, Gubbels JW. A randomized, placebo-controlled trial of exercise therapy in patients with acute low back pain. Spine 1993;18:1388-1395
    Web of Science | Medline

  32. 32

    Walton RE, Chiappinelli J. Prophylactic penicillin: effect on posttreatment symptoms following root canal treatment of asymptomatic periapical pathosis. J Endod 1993;19:466-470
    CrossRef | Web of Science | Medline

  33. 33

    McMillan CM. Transcutaneous electrical stimulation of Neiguan anti-emetic acupuncture point in controlling sickness following opioid analgesia in major orthopaedic surgery. Physiotherapy 1994;80:5-9
    CrossRef

  34. 34

    Najningier B, Patowski W, Zieniewicz K, et al. Zofran w zapobieganiu nudnosciom i wymiotom po cholecystektomii laparoskopowej. Acta Endosc Pol 1997;7:125-128

  35. 35

    Dundee JW, Chestnutt WN, Ghaly RG, Lynas AGA. Traditional Chinese acupuncture: a potentially useful antiemetic? BMJ 1986;293:583-584
    CrossRef | Web of Science | Medline

  36. 36

    Adriaanse AH, Kollee LAA, Muytjens HL, Nijhuis JG, de Haan AFJ, Eskes TKAB. Randomized study of vaginal chlorhexidine disinfection during labor to prevent vertical transmission of group B streptococci. Eur J Obstet Gynecol Reprod Biol 1995;61:135-141
    CrossRef | Web of Science | Medline

  37. 37

    Harrison RF, de Louvois J, Blades M, Hurley R. Doxycycline treatment and human infertility. Lancet 1975;1:605-607
    CrossRef | Web of Science | Medline

  38. 38

    Aune A, Alraek T, Huo L, Barheim A. Kan akupunktur forebygge blærekatarr hos kvinner? Tidsskr Nor Laegeforen 1998;118:1370-1372
    Medline

  39. 39

    Heinzl S, Andor J. Preoperative administration of prostaglandin to avoid dilatation-induced damage in first-trimester pregnancy terminations. Gynecol Obstet Invest 1981;12:29-36
    CrossRef | Web of Science | Medline

  40. 40

    Tarrier N, Yusupoff L, Kinney C, et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ 1998;317:303-307
    CrossRef | Web of Science | Medline

  41. 41

    Whittaker CB, Hoy RM. Withdrawal of perphenazine in chronic schizophrenia. Br J Psychiatry 1963;109:422-427
    CrossRef | Web of Science | Medline

  42. 42

    Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47:1093-1099
    Web of Science | Medline

  43. 43

    Klerman GL, Dimascio A, Weisman M, Prusoff B, Paykel ES. Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974;131:186-191
    Web of Science | Medline

  44. 44

    Rabkin JG, McGrath PJ, Quitkin FM, Tricamo E, Stewart JW, Klein DF. Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. Am J Psychiatry 1990;147:1622-1626
    Web of Science | Medline

  45. 45

    Roughan PA, Kunst L. Do pelvic floor exercises really improve orgasmic potential? J Sex Marital Ther 1981;7:223-229
    CrossRef | Web of Science | Medline

  46. 46

    Berg I, Forsythe I, Holt P, Watts J. A controlled trial of `Senokot' in faecal soiling treated by behavioral methods. J Child Psychol Psychiatry 1983;24:543-549
    CrossRef | Web of Science | Medline

  47. 47

    Blackman S, Benton AJ, Cove LM. The effect of imipramine on enuresis. Am J Psychiatry 1964;120:1194-1195
    Web of Science | Medline

  48. 48

    Double DB, Warren GC, Evans M, Rowlands RP. Efficacy of maintenance use of anticholinergic agents. Acta Psychiatr Scand 1993;88:381-384
    CrossRef | Web of Science | Medline

  49. 49

    Stransky M, Rubin A, Lava NS, Lazaro RP. Treatment of carpal tunnel syndrome with vitamin B6: a double-blind study. South Med J 1989;82:841-842
    CrossRef | Web of Science | Medline

  50. 50

    Tan S, Bruni J. Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia 1986;27:225-233
    CrossRef | Web of Science | Medline

  51. 51

    Antivalle M, Lattuada S, Salvaggio M, Paravicini M, Rindi M, Libretti A. Placebo effect and adaptation to noninvasive monitoring of BP. J Hum Hypertens 1990;4:633-637
    Web of Science | Medline

  52. 52

    Bosley F, Allen TW. Stress management training for hypertensives: cognitive and physiological effects. J Behav Med 1989;12:77-89
    CrossRef | Web of Science | Medline

  53. 53

    Canino E, Cardona R, Monsalve P, Acuna FP, Lopez B, Fragachan F. A behavioral treatment program as a therapy in the control of primary hypertension. Acta Cient Venez 1994;45:23-30
    Medline

  54. 54

    Frankel BL, Patel DJ, Horwitz D, Friedewald WT, Gaarder KR. Treatment of hypertension with biofeedback and relaxation techniques. Psychosom Med 1978;40:276-293
    Web of Science | Medline

  55. 55

    Rossi A, Ziacchi V, Lomanto B. The hypotensive effect of a single daily dose of labetalol: a preliminary study. Int J Clin Pharmacol Ther Toxicol 1982;20:438-445
    Medline

  56. 56

    Seer P, Raeburn JM. Meditation training and essential hypertension: a methodological study. J Behav Med 1980;3:59-71
    CrossRef | Medline

  57. 57

    Yates RG, Lamping DL, Abram NL, Wright C. Effects of chiropractic treatment on blood pressure and anxiety: a randomized, controlled trial. J Manipulative Physiol Ther 1988;11:484-488
    Web of Science | Medline

  58. 58

    Block J. Effects of rational emotive therapy on overweight adults. Psychother Theory Res Pract 1980;17:277-280
    CrossRef | Web of Science

  59. 59

    Hall RG, Hanson RW, Borden BL. Permanence of two self-managed treatments of overweight in university and community populations. J Consult Clin Psychol 1974;42:781-786
    CrossRef | Web of Science | Medline

  60. 60

    Hanson RW, Borden BL, Hall SM, Hall RG. Use of programmed instruction in teaching self-management skills to overweight adults. Behav Ther 1976;7:366-373
    CrossRef | Web of Science

  61. 61

    Murphy JK, Williamson DA, Buxton AE, Moody SC, Absher N, Warner M. The long-term effects of spouse involvement upon weight loss and maintenance. Behav Ther 1982;13:681-693
    CrossRef | Web of Science

  62. 62

    Senediak C, Spence SH. Rapid versus gradual scheduling of therapeutic contact in a family based behavioral weight control programme for children. Behav Psychother 1985;13:265-287
    CrossRef | Web of Science

  63. 63

    Godfrey S, Silverman M. Demonstration of a placebo response in asthma by means of exercise testing. J Psychosom Res 1973;17:293-297
    CrossRef | Web of Science | Medline

  64. 64

    May O, Hansen NCG. Comparison of terbutaline, isotonic saline, ambient air and non-treatment in patients with reversible chronic airway obstruction. Eur Respir J 1988;1:527-530
    Web of Science | Medline

  65. 65

    Morton AR, Fazio SM, Miller D. Efficacy of laser-acupuncture in the prevention of exercise-induced asthma. Ann Allergy 1993;70:295-298
    Medline

  66. 66

    Lindholm LH, Ekbom T, Dash C, Isacsson A, Schersten B. Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study. J Intern Med 1996;240:13-22
    CrossRef | Web of Science | Medline

  67. 67

    Tuomilehto J, Voutilainen E, Huttunen J, Vinni S, Homan K. Effect of guar gum on body weight and serum lipids in hypercholesterolemic females. Acta Med Scand 1980;208:45-48
    CrossRef | Web of Science | Medline

  68. 68

    Diamond L, Dockhorn RJ, Grossman J, et al. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol 1995;95:1139-1146
    CrossRef | Web of Science | Medline

  69. 69

    Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT. Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:89-97
    Web of Science | Medline

  70. 70

    Stabholz A, Shapira J, Shur D, Friedman M, Guberman R, Sela MN. Local application of sustained-release delivery system of chlorhexidine in Down's syndrome population. Clin Prev Dent 1991;13:9-14
    Medline

  71. 71

    Stewart JE, Jacobs-Schoen M, Padilla MR, Maeder LA, Wolfe GR, Hartz GW. The effect of a cognitive behavioral intervention on oral hygiene. J Clin Periodontol 1991;18:219-222
    CrossRef | Web of Science | Medline

  72. 72

    Sipich JF, Russell RK, Tobias LL. A comparison of covert sensitization and “nonspecific“ treatment in the modification of smoking behavior. J Behav Ther Exp Psychiatry 1974;5:201-203
    CrossRef | Web of Science

  73. 73

    Spanos NP, Mondoux TJ, Burges CA. Comparison of multi-component hypnotic and non-hypnotic treatments for smoking. Contemp Hypn 1995;12:12-19

  74. 74

    Longo DJ, Clum GA, Yaeger NJ. Psychosocial treatment for recurrent genital herpes. J Consult Clin Psychol 1988;56:61-66
    CrossRef | Web of Science | Medline

  75. 75

    Crosby L, Palarski VA, Cottington E, Cmolik B. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart Lung 1994;23:493-499
    Web of Science | Medline

  76. 76

    Karunakaran S, Hammersley MS, Morris RC, Turner RC, Holman RR. The Fasting Hyperglycaemia Study. III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose. Metabolism 1997;46:Suppl 1:56-60
    CrossRef | Web of Science | Medline

  77. 77

    Nawrocki JD, Bell TJ, Lawrence WT, Ward JP. A randomized controlled trial of transurethral microwave thermotherapy. Br J Urol 1997;79:389-393
    CrossRef | Medline

  78. 78

    GRECHO, U292 INSERM, ARC, GREPA. Evaluation de deux produits homéopathiques sur la reprise du transit après chirurgie digestive: un essai contrôlé multicentrique. Presse Med 1989;18:59-62
    Web of Science | Medline

  79. 79

    Nyboe Andersen A, Damm P, Tabor A, Pedersen IM, Harring M. Prevention of breast pain and milk secretion with bromocriptine after second-trimester abortion. Acta Obstet Gynecol Scand 1990;69:235-238
    CrossRef | Web of Science | Medline

  80. 80

    Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995;346:1231-1231
    CrossRef | Web of Science | Medline

  81. 81

    Benedetti F, Amanio M, Casadio C, et al. Control of postoperative pain by transcutaneous electrical nerve stimulation after thoracic operations. Ann Thorac Surg 1997;63:773-776
    CrossRef | Web of Science | Medline

  82. 82

    Chenard JR, Marchand S, Charest J, Jinxue L, Lavignolle B. Évaluation d'un traitement comportmental de la lombalgie chronique: l'école interactionelle du dos. Sci Comportement 1991;21:225-239

  83. 83

    Classen W, Feingold E, Netter P. Influence of sensory suggestibility on treatment outcome in headache patients. Neuropsychobiology 1983;10:44-47
    CrossRef | Web of Science | Medline

  84. 84

    Conn IG, Marshall AH, Yadav SN, Daly JC, Jaffer M. Transcutaneous electrical nerve stimulation following appendicectomy: the placebo effect. Ann R Coll Surg Engl 1986;68:191-192
    Web of Science | Medline

  85. 85

    Coyne P, MacMurren M, Izzo T, Kramer T. Transcutaneous electrical nerve stimulator for procedural pain associated with intravenous needlesticks. J Intraven Nurs 1995;18:263-267
    Medline

  86. 86

    Forster EL, Kramer JF, Lucy SD, Scudds RA, Novick RJ. Effects of TENS on pain, medications, and pulmonary function following coronary artery bypass graft surgery. Chest 1994;106:1343-1348
    CrossRef | Web of Science | Medline

  87. 87

    Frega A, Stentella P, Di Renzi F, et al. Pain evaluation during carbon dioxide laser vaporization for cervical intraepithelial neoplasia: a randomized trial. Clin Exp Obstet Gynecol 1994;21:188-191
    Medline

  88. 88

    Goodenough B, Kampel L, Champion GD, et al. An investigation of the placebo effect and age-related factors in the report of needle pain from venipuncture in children. Pain 1997;72:383-391
    CrossRef | Web of Science | Medline

  89. 89

    Gracely RH, Dubner R, Wolskee PJ, Deeter WR. Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature 1983;306:264-265
    CrossRef | Web of Science | Medline

  90. 90

    Hargreaves A, Lander J. Use of transcutaneous electrical nerve stimulation for postoperative pain. Nurs Res 1989;38:159-161
    CrossRef | Web of Science | Medline

  91. 91

    Hashish I, Harvey W, Harris M. Anti-inflammatory effects of ultrasound therapy: evidence for a major placebo effect. Br J Rheumatol 1986;25:77-81
    CrossRef | Medline

  92. 92

    Hashish I, Hai HK, Harvey W, Feinmann C, Harris M. Reduction of postoperative pain and swelling by ultrasound treatment: a placebo effect. Pain 1988;33:303-311
    CrossRef | Web of Science | Medline

  93. 93

    Helms JM. Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol 1987;69:51-56
    Web of Science | Medline

  94. 94

    Hong CZ, Chen YC, Pon CH, Yu J. Immediate effects of various physical medicine modalities on pain threshold of an active myofascial trigger point. Musculoskeletal Pain 1993;1:37-53
    CrossRef

  95. 95

    Lander J, Fowler-Kerry S. TENS for children's procedural pain. Pain 1993;52:209-216
    CrossRef | Web of Science | Medline

  96. 96

    Levine JD, Gordon NC. Influence of the method of drug administration on analgesic response. Nature 1984;312:755-756
    CrossRef | Web of Science | Medline

  97. 97

    Moffett JAK, Richardson PH, Frost H, Osborn A. A placebo controlled double blind trial to evaluate the effectiveness of pulsed short wave therapy for osteoarthritic hip and knee pain. Pain 1996;67:121-127
    CrossRef | Web of Science | Medline

  98. 98

    Parker JC, Smarr KL, Buckelew SP, et al. Effects of stress management on clinical outcomes in rheumatoid arthritis. Arthritis Rheum 1995;38:1807-1818
    CrossRef | Web of Science | Medline

  99. 99

    Reading AE. The effects of psychological preparation on pain and recovery after minor gynaecological surgery: a preliminary report. J Clin Psychol 1982;38:504-512
    CrossRef | Web of Science | Medline

  100. 100

    Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
    CrossRef | Web of Science | Medline

  101. 101

    Sanders GE, Reinert O, Tepe R, Maloney P. Chiropractic adjustive manipulation on subjects with acute low back pain: visual analog pain scores and plasma beta-endorphin levels. J Manipulative Physiol Ther 1990;13:391-395
    Web of Science | Medline

  102. 102

    Sprott H, Mennet P, Stratz T, Muller W. Wirksamkeit der Akupunktur bei Patienten mit generalisierter Tendomyopathie (Fibromyalgie). Aktuel Rheumatol 1993;18:132-135
    CrossRef | Web of Science

  103. 103

    Tan S, Poser EG. Acute pain in a clinical setting: effects of cognitive-behavioural skills training. Behav Res Ther 1982;20:535-545
    CrossRef | Web of Science | Medline

  104. 104

    Vlaeyen JWS, Teeken-Gruben NJG, Goossens MEJB, et al. Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. J Rheumatol 1996;23:1237-1245
    Web of Science | Medline

  105. 105

    Wojciechowski FL. Behavioral treatment of tension headache: a contribution to controlled outcome research methodology. Gedrag Tijdschrift Voor Psychol 1984;12:16-30

  106. 106

    Hawkins PJ, Liossi C, Ewart BW, Hatria P, Kosmidis VH, Varvutsi M. Hypnotherapy for control of anticipatory nausea and vomiting in children with cancer: preliminary findings. Psychooncology 1995;4:101-106
    CrossRef | Web of Science

  107. 107

    O'Brien B, Relyea MJ, Taerum T. Efficacy of P6 acupressure in the treatment of nausea and vomiting during pregnancy. Am J Obstet Gynecol 1996;174:708-715
    CrossRef | Web of Science | Medline

  108. 108

    Tremeau ML, Fontanie-Ravier P, Teurnier F, Demouzon J. Protocole de maturation cervicale par acupuncture. J Gynecol Obstet Biol Reprod (Paris) 1992;21:375-380
    Medline

  109. 109

    Irvin JH, Domar AD, Clark C, Zuttermeister PC, Friedman R. The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynaecol 1996;17:202-207
    CrossRef | Web of Science | Medline

  110. 110

    Ascher LM, Turner RM. Paradoxical intention and insomnia: an experimental investigation. Behav Res Ther 1979;17:408-411
    CrossRef | Web of Science | Medline

  111. 111

    Espie CA, Lindsay WR, Brooks DN, Hood EM, Turvey T. A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behav Res Ther 1989;27:79-88
    CrossRef | Web of Science | Medline

  112. 112

    Lick JR, Heffler D. Relaxation training and attention placebo in the treatment of severe insomnia. J Consult Clin Psychol 1977;45:153-161
    CrossRef | Web of Science | Medline

  113. 113

    Nicassio P, Bootzin R. A comparison of progressive relaxation and autogenic training as treatments for insomnia. J Abnorm Psychol 1974;83:253-260
    CrossRef | Web of Science | Medline

  114. 114

    Turner RM, Ascher LM. Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. J Consult Clin Psychol 1979;47:500-508
    CrossRef | Web of Science | Medline

  115. 115

    Kendall PC, Williams L, Pechacek TF, Graham LE, Shisslak C, Herzoff N. Cognitive-behavioral and patient education interventions in cardiac catheterization: the Palo Alto Medical Psychology Project. J Consult Clin Psychol 1979;47:49-58
    CrossRef | Web of Science | Medline

  116. 116

    Lorr M, McNair DM, Weinstein GJ, Michaux WW, Raskin A. Meprobamate and chlorpromazine in psychotherapy: same effects on anxiety and hostility of outpatients. Arch Gen Psychiatry 1961;4:381-389
    Web of Science | Medline

  117. 117

    Macaluso AD, Connelly AM, Hayes WB, et al. Oral transmucosal fentanyl citrate for premedication in adults. Anesth Analg 1996;82:158-161
    CrossRef | Web of Science | Medline

  118. 118

    Markland D, Hardy L. Anxiety, relaxation and anaesthesia for day-case surgery. Br J Clin Psychol 1993;32:493-504
    CrossRef | Web of Science | Medline

  119. 119

    Rybarczyk BD, Auerbach SM. Reminiscence interviews as stress management interventions for older patients undergoing surgery. Gerontologist 1990;30:522-528
    CrossRef | Web of Science | Medline

  120. 120

    Theroux MC, West DW, Corddry DH, et al. Efficacy of intranasal midazolam in facilitating suturing of lacerations in preschool children in the emergency department. Pediatrics 1993;9:624-627

  121. 121

    Lick J. Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. J Consult Clin Psychol 1975;43:557-567
    CrossRef | Web of Science | Medline

  122. 122

    Rosen GM, Glasgow RE, Barrera M. A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. J Consult Clin Psychol 1976;44:208-217
    CrossRef | Web of Science | Medline

  123. 123

    Fuchs CZ, Rehm LP. A self-control behavior therapy program for depression. J Consult Clin Psychol 1977;45:206-215
    CrossRef | Web of Science | Medline

  124. 124

    Nandi DN, Ajmany S, Ganguli H, et al. A clinical evaluation of depressives found in a rural survey in India. Br J Psychiatry 1976;128:523-527
    CrossRef | Web of Science | Medline

  125. 125

    Davidson AM, Denney DR, Elliott CH. Suppression and substitution in the treatment of nailbiting. Behav Res Ther 1980;18:1-9
    CrossRef | Web of Science | Medline

  126. 126

    Bramston P, Spence SH. Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behav Res Ther 1985;23:239-246
    CrossRef | Web of Science | Medline

  127. 127

    Jacobson NS. Specific and nonspecific factors in the effectiveness of a behavioral approach to the treatment of marital discord. J Consult Clin Psychol 1978;46:442-452
    CrossRef | Web of Science | Medline

  128. 128

    Nocella J, Kaplan RM. Training children to cope with dental treatment. J Pediatr Psychol 1982;7:175-178
    CrossRef | Medline

  129. 129

    Weingaertner AH. Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. J Consult Clin Psychol 1971;36:422-429
    CrossRef | Web of Science | Medline

  130. 130

    Crapper McLachlan DR, Dalton AJ, Kruck TPA, et al. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 1991;337:1304-1308[Erratum, Lancet 1991;337:1618.]
    CrossRef | Web of Science | Medline

  131. 131

    Quayhagen MP, Quayhagen M, Corbeil RR, Roth P, Rodgers JA. A dyadic remediation program for care recipients with dementia. Nurs Res 1995;44:153-159
    CrossRef | Web of Science | Medline

  132. 132

    Pelham WE, Murphy DA, Vannatta K, et al. Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. J Consult Clin Psychol 1992;60:282-292
    CrossRef | Web of Science | Medline

  133. 133

    Ernst E, Resch KL. Concept of true and perceived placebo effects. BMJ 1995;311:551-553
    CrossRef | Web of Science | Medline

  134. 134

    Gotzsche PC. Sensitivity of effect variables in rheumatoid arthritis: a meta-analysis of 130 placebo controlled NSAID trials. J Clin Epidemiol 1990;43:1313-1318[Erratum, J Clin Epidemiol 1991;44:613.]
    CrossRef | Web of Science | Medline

  135. 135

    Adams HG, Benson EA, Alexander ER, Ventrer LA, Remington MA, Holmes KK. Genital herpetic infection in men and women: clinical course and effect of topical application of adenine arabinoside. J Infect Dis 1976;133:Suppl:A151-A159
    CrossRef | Web of Science | Medline

  136. 136

    Banner CN, Meadows WM. Examination of the effectiveness of various treatment techniques for reducing tension. Br J Clin Psychol 1983;22:183-193
    CrossRef | Web of Science | Medline

  137. 137

    Brill NQ, Koegler RR, Epstein LJ, Forgy EW. Controlled study of psychiatric outpatient treatment. Arch Gen Psychiatry 1964;10:581-595
    Web of Science | Medline

  138. 138

    Doty DW. Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. J Consult Clin Psychol 1975;43:676-682
    CrossRef | Web of Science | Medline

  139. 139

    Gracely RH, Deeter WR, Wolskee PJ, et al. The effect of naloxone on multidimensional scales of postsurgical pain in nonsedated patients. Soc Neurosci Abstr 1979;5:609-609

  140. 140

    Grammer LC, Shaughnessy MA, Shaughnessy JJ, Patterson R. Asthma as a variable in a study of immunotherapy for allergic rhinitis. J Allergy Clin Immunol 1984;73:557-560
    CrossRef | Web of Science | Medline

  141. 141

    Hallstrom C, Crouch G, Robsen M, Shine P. The treatment of tranquillizer dependence by propranolol. Postgrad Med J 1988;64:Suppl 2:40-44
    Web of Science | Medline

  142. 142

    Irjala J, Kanto J, Scheinin M. Monoamine metabolite and catecholamine measurements in cerebrospinal fluid in determining the quality of the pre-operative night's sleep. Eur J Anaesthesiol 1993;10:393-396
    Web of Science | Medline

  143. 143

    Jakes SC, Hallam RS, McKenna L, Hinchcliffe R. Group cognitive therapy for medical patients: an application to tinnitus. Cognit Ther Res 1992;16:67-82
    CrossRef | Web of Science

  144. 144

    Lamazza A, Tofi A, Bolognese A, Fontana B, De Masi E, Frontespezi S. Effects of pinaverium bromide in the premedication of endoscopic retrograde cholangio-pancreatography and on motor activity of the sphincter of Oddi. Cur Med Res Opin 1986;10:280-284
    CrossRef | Web of Science | Medline

  145. 145

    Levitt M, Wilson A, Bowman D, et al. Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10 and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy: ophthalmologic implications. J Clin Pharmacol 1981;21:Suppl 8-9:103S-109S
    CrossRef | Web of Science | Medline

  146. 146

    Mussell MJ, Hartley JP. Trachea-noise biofeedback in asthma: a comparison of the effect of trachea-noise biofeedback, a bronchodilator, and no treatment on the rate of recovery from exercise- and eucapnic hyperventilation-induced asthma. Biofeedback Self Regul 1988;13:219-234
    CrossRef | Medline

  147. 147

    Pearl D, Vander Kamp H, Olsen AL, Greenberg PD, Armitage SG. The effects of reserpine on schizophrenic patients. Am J Psychiatry 1956;112:936-936
    Web of Science | Medline

  148. 148

    Rupert PA, Holmes DS. Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology 1978;15:582-590
    CrossRef | Web of Science | Medline

  149. 149

    Sibilio JP, Andrew G, Dart D, Moore KB, Stehman VA. Treatment of chronic schizophrenia with promazine hydrochloride. AMA Arch Neurol Psychiatry 1957;78:419-424
    Web of Science | Medline

  150. 150

    Sommerness MD, Lucero RJ, Hamlon JS, Erickson JL, Matthews R. A controlled study of reserpine on chronically disturbed patients. AMA Arch Neurol Psychiatry 1955;74:316-319
    Web of Science | Medline

Citing Articles (596)

Citing Articles

  1. 1

    Daniel M. Goldenholz, Shira R. Goldenholz. (2016) Response to placebo in clinical epilepsy trials—Old ideas and new insights. Epilepsy Research 122, 15-25
    CrossRef

  2. 2

    Lene Vase, Ina Skyt, Kathryn T. Hall. (2016) Placebo, nocebo, and neuropathic pain. PAIN 157, S98-S105
    CrossRef

  3. 3

    D. Gourion, S. Mouchabac. (2016) L'effet placebo : implications cliniques, biologiques, et thérapeutiques dans la dépression. L'Encéphale 42, 1S24-1S30
    CrossRef

  4. 4

    Jeremy Howick. (2016) The relativity of ‘placebos’: defending a modified version of Grünbaum’s definition. Synthese
    CrossRef

  5. 5

    Jack E. James. . Placebo and the Therapeutic Process. 2016:, 307-329.
    CrossRef

  6. 6

    Yan Chen, Yong-Can Huang, William W Lu. (2016) Low-dose versus high-dose fish oil for pain reduction and function improvement in patients with knee osteoarthritis. Annals of the Rheumatic Diseases 75, e7-e7
    CrossRef

  7. 7

    Donald D. Price, Lene Vase. . Integrating Memory, Meaning, and Emotions during Placebo Analgesia and Nocebo Hyperalgesia. 2016:, 159-178.
    CrossRef

  8. 8

    José W. Geurts, Jan-Willem Kallewaard, Alfons Kessels, Paul C. Willems, Henk van Santbrink, Carmen Dirksen, Maarten van Kleef. (2015) Efficacy and cost-effectiveness of intradiscal methylene blue injection for chronic discogenic low back pain: study protocol for a randomized controlled trial. Trials 16
    CrossRef

  9. 9

    D Shaw, M Frass, M Oberbaum. (2015) A pragmatic decision to avoid blinding, placebos and disclosure of conflicts of interest: an RCT of homeopathy for cancer patients. Focus on Alternative and Complementary Therapies 20:10.1111/fct.2015.20.issue-3-4, 159-161
    CrossRef

  10. 10

    Seunghoon Lee, Dongwoo Nam, Jungtae Leem, Gajin Han, Seungmin Lee, Junhee Lee. (2015) Efficacy and safety of Myofascial-meridian Release Acupuncture (MMRA) for chronic neck pain: a study protocol for randomized, patient- and assessor-blinded, sham controlled trial. BMC Complementary and Alternative Medicine 16
    CrossRef

  11. 11

    Harald Walach, Martin Loef. (2015) Using a matrix-analytical approach to synthesizing evidence solved incompatibility problem in the hierarchy of evidence. Journal of Clinical Epidemiology 68, 1251-1260
    CrossRef

  12. 12

    Grace Petkovic, James E G Charlesworth, John Kelley, Franklin Miller, Nia Roberts, Jeremy Howick. (2015) Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis: Table 1. BMJ Open 5, e009428
    CrossRef

  13. 13

    Ya-yun Lee, Keh-chung Lin, Ching-yi Wu, Ching-hua Liao, Jui-chi Lin, Chia-ling Chen. (2015) Combining Afferent Stimulation and Mirror Therapy for Improving Muscular, Sensorimotor, and Daily Functions After Chronic Stroke. American Journal of Physical Medicine & Rehabilitation 94, 859-868
    CrossRef

  14. 14

    Rune Hedlund, Christer Johansson, Olle Hägg, Peter Fritzell, Tycho Tullberg. (2015) The long-term outcome of lumbar fusion in the Swedish lumbar spine study. The Spine Journal
    CrossRef

  15. 15

    Michael Perlis, Michael Grandner, Jarcy Zee, Erin Bremer, Julia Whinnery, Holly Barilla, Priscilla Andalia, Phil Gehrman, Knashawn Morales, Michael Thase, Richard Bootzin, Robert Ader. (2015) Durability of treatment response to zolpidem with three different maintenance regimens: a preliminary study. Sleep Medicine 16, 1160-1168
    CrossRef

  16. 16

    Jungtae Leem. (2015) Is acupuncture effective for functional recovery in ischemic stroke?. Integrative Medicine Research 4, 185-188
    CrossRef

  17. 17

    Abhishek Abhishek, Michael Doherty. (2015) Comprendre l’effet placebo en rhumatologie. Revue du Rhumatisme 82, 211-213
    CrossRef

  18. 18

    Michael Frass, Helmut Friehs, Christiane Thallinger, Narinderjit Kaur Sohal, Christine Marosi, Ilse Muchitsch, Katharina Gaertner, Andreas Gleiss, Ernst Schuster, Menachem Oberbaum. (2015) Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients – A pragmatic randomized controlled trial. Complementary Therapies in Medicine 23, 309-317
    CrossRef

  19. 19

    Alia Crum, Damon J. Phillips. . Self-Fulfilling Prophesies, Placebo Effects, and the Social-Psychological Creation of Reality. 2015:, 1-14.
    CrossRef

  20. 20

    Robert A. Scott. . The Role of Cultural, Social, and Psychological Factors in Disease and Illness. 2015:, 1-10.
    CrossRef

  21. 21

    C. Zeng, J. Wei, G.-h. Lei. (2015) Is chondroitin sulfate plus glucosamine superior to placebo in the treatment of knee osteoarthritis?. Annals of the Rheumatic Diseases 74, e37-e37
    CrossRef

  22. 22

    Jacob B. Lindheimer, Patrick J. O’Connor, Rod K. Dishman. (2015) Quantifying the Placebo Effect in Psychological Outcomes of Exercise Training: A Meta-Analysis of Randomized Trials. Sports Medicine 45, 693-711
    CrossRef

  23. 23

    Fatma Begüm Erol, Romain J. Forestier, Fulya Demircioğlu Güneri, M. Zeki Karagülle, Nergis Erdoğan. (2015) Spa Therapy for Generalized Osteoarthritis: an Open, Observational, Preliminary Study. Thérapie 70, 273-281
    CrossRef

  24. 24

    Xiao Xu, Wei Ji, Xiu-Qiang Lv, Yi-Chi Zhu, Ji-Xiang Zhao, Lin-Zhong Miao. (2015) Impact of physical activity on health-related quality of life in osteoporotic and osteopenic postmenopausal women: A systematic review. International Journal of Nursing Sciences
    CrossRef

  25. 25

    David E. Sandberg, Melissa Gardner. (2015) Short Stature. Pediatric Clinics of North America
    CrossRef

  26. 26

    Sophie L. Niemansburg, Johannes J.M. van Delden, Wouter J.A. Dhert, Annelien L. Bredenoord. (2015) Reconsidering the ethics of sham interventions in an era of emerging technologies. Surgery 157, 801-810
    CrossRef

  27. 27

    Claudio G Sosa, Fernando Althabe, José M Belizán, Eduardo Bergel, Claudio G Sosa. . Bed rest in singleton pregnancies for preventing preterm birth. 2015.
    CrossRef

  28. 28

    L. F. Sandal, J. B. Thorlund, R. S. Ulrich, P. A. Dieppe, E. M. Roos. (2015) Exploring the effect of space and place on response to exercise therapy for knee and hip pain--a protocol for a double-blind randomised controlled clinical trial: the CONEX trial. BMJ Open 5, e007701-e007701
    CrossRef

  29. 29

    Katja Weimer, Luana Colloca, Paul Enck. (2015) Placebo effects in psychiatry: mediators and moderators. The Lancet Psychiatry 2, 246-257
    CrossRef

  30. 30

    Abhishek Abhishek, Michael Doherty. (2015) Understanding placebo effects in rheumatology. Joint Bone Spine
    CrossRef

  31. 31

    Verheye , Stefan , Jolicœur , E. Marc , Behan , Miles W. , Pettersson , Thomas , Sainsbury , Paul , Hill , Jonathan , Vrolix , Mathias , Agostoni , Pierfrancesco , Engstrom , Thomas , Labinaz , Marino , de Silva , Ranil , Schwartz , Marc , Meyten , Nathalie , Uren , Neal G. , Doucet , Serge , Tanguay , Jean-François , Lindsay , Steven , Henry , Timothy D. , White , Christopher J. , Edelman , Elazer R. , Banai , Shmuel , . (2015) Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina. New England Journal of Medicine 372:6, 519-527
    Free Full Text

  32. 32

    Gashirai K. Mbizvo, Sarah J. Nolan, Turo J. Nurmikko, Andreas Goebel. (2015) Placebo Responses in Long-Standing Complex Regional Pain Syndrome: A Systematic Review and Meta-Analysis. The Journal of Pain 16, 99-115
    CrossRef

  33. 33

    D. Carr. (2015) Somatosensory stimulation and assisted reproduction. Acupuncture in Medicine 33, 2-6
    CrossRef

  34. 34

    Jonathan Pugh. (2015) Ravines and Sugar Pills: Defending Deceptive Placebo Use. Journal of Medicine and Philosophy 40, 83-101
    CrossRef

  35. 35

    Mohammad Reza Amiri-Nikpour, Surena Nazarbaghi, Milad Hamdi-Holasou, Yousef Rezaei. (2015) An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect. Acta Neurologica Scandinavica 131, 45-50
    CrossRef

  36. 36

    Matthew D. Haydock, Anubhav Mittal, Carissa F. Wilkes, David H. Lim, Elizabeth Broadbent, John A. Windsor. (2015) INTERACTION BETWEEN OBJECTIVE PERFORMANCE MEASURES AND SUBJECTIVE USER PERCEPTIONS IN THE EVALUATION OF MEDICAL DEVICES: A CASE STUDY. International Journal of Technology Assessment in Health Care 31, 297-303
    CrossRef

  37. 37

    Ulrike Bingel. (2014) Placeboeffekte und ihre Implikationen in der Medizin. HNO Nachrichten 44, 27-38
    CrossRef

  38. 38

    Tracey A. Ignatowski, Robert N. Spengler, Edward Tobinick. (2014) Authors’ Reply to Whitlock: Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence. CNS Drugs 28, 1207-1213
    CrossRef

  39. 39

    Jean-Pascal Lefaucheur, Nathalie André-Obadia, Andrea Antal, Samar S. Ayache, Chris Baeken, David H. Benninger, Roberto M. Cantello, Massimo Cincotta, Mamede de Carvalho, Dirk De Ridder, Hervé Devanne, Vincenzo Di Lazzaro, Saša R. Filipović, Friedhelm C. Hummel, Satu K. Jääskeläinen, Vasilios K. Kimiskidis, Giacomo Koch, Berthold Langguth, Thomas Nyffeler, Antonio Oliviero, Frank Padberg, Emmanuel Poulet, Simone Rossi, Paolo Maria Rossini, John C. Rothwell, Carlos Schönfeldt-Lecuona, Hartwig R. Siebner, Christina W. Slotema, Charlotte J. Stagg, Josep Valls-Sole, Ulf Ziemann, Walter Paulus, Luis Garcia-Larrea. (2014) Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology 125, 2150-2206
    CrossRef

  40. 40

    Hikaru Takeuchi, Yasuyuki Taki, Rui Nouchi, Hiroshi Hashizume, Atsushi Sekiguchi, Yuka Kotozaki, Seishu Nakagawa, Carlos Makoto Miyauchi, Yuko Sassa, Ryuta Kawashima. (2014) Working memory training improves emotional states of healthy individuals. Frontiers in Systems Neuroscience 8
    CrossRef

  41. 41

    Hong Mei Wu, Hong Juan Sun, Feng Wang, Ming Yang, Bi Rong Dong, Guan J Liu, Hong Mei Wu. . Oral adsorbents for preventing or delaying the progression of chronic kidney disease. 2014.
    CrossRef

  42. 42

    Kenneth F. Schulz. . Double-Dummy. 2014.
    CrossRef

  43. 43

    Anne Holbrook, Charles H. Goldsmith, Mova Leung. . Placebos. 2014:, 725-735.
    CrossRef

  44. 44

    Jean-Christophe Dumont, Philippe Bertin, Pascale Vergne-Salle, Dominique Malauzat, Murielle Girard, Richard Treves. (2014) Étude de faisabilité d’un traitement par rTMS dans la fibromyalgie, à propos de 20 patients. Douleurs : Evaluation - Diagnostic - Traitement 15, 174-191
    CrossRef

  45. 45

    Si-Woon Park, Sook-Hee Yi, Jung Ah Lee, Pil Woo Hwang, Hyun Cheol Yoo, Kyoung Sook Kang. (2014) Acupuncture for the Treatment of Spasticity After Stroke: A Meta-Analysis of Randomized Controlled Trials. The Journal of Alternative and Complementary Medicine 20, 672-682
    CrossRef

  46. 46

    Ayse Istek, Funda Gungor Ugurlucan, Cenk Yasa, Sule Gokyildiz, Onay Yalcin. (2014) Randomized trial of long-term effects of percutaneous tibial nerve stimulation on chronic pelvic pain. Archives of Gynecology and Obstetrics 290, 291-298
    CrossRef

  47. 47

    K. Ammer. (2014) Schmerzreduktion durch Plazebomanipulation versus tatsächliche Manualtherapie. Manuelle Medizin 52, 346-348
    CrossRef

  48. 48

    Stefanie Dutile, Ted J. Kaptchuk, Michael E. Wechsler. (2014) The Placebo Effect in Asthma. Current Allergy and Asthma Reports 14
    CrossRef

  49. 49

    Gitte Laue Petersen, Nanna Brix Finnerup, Luana Colloca, Martina Amanzio, Donald D. Price, Troels Staehelin Jensen, Lene Vase. (2014) The magnitude of nocebo effects in pain: A meta-analysis. PAIN® 155, 1426-1434
    CrossRef

  50. 50

    Bonnie Wright, Jessica K. Rychel. . Treatment and Assessment of Chronic Pain in Cats. 2014:, 289-298.
    CrossRef

  51. 51

    QiQi Zhou, G. Nicholas Verne. (2014) Neurogastroenterology: Neuronal correlates of placebo in chronic FGIDs. Nature Reviews Gastroenterology & Hepatology 11, 460-461
    CrossRef

  52. 52

    David Roberts, Frank Li. (2014) The presentation and outcomes of shoulder pain in public hospital physiotherapy departments in NSW: an observational study. Physiotherapy Theory and Practice 30, 299-305
    CrossRef

  53. 53

    N. Chemmam El Kadhi, C. Dziri, S. Koubaa, I. Miri, S. Lebib, F.-Z. Ben Salah. (2014) Prévention de la douleur par le mélange équimolaire oxygène protoxyde d’azote (MEOPA) au cours de l’exploration uro-dynamique chez l’enfant. Journal de Réadaptation Médicale : Pratique et Formation en Médecine Physique et de Réadaptation 34, 43-52
    CrossRef

  54. 54

    Vera Lucia Rasera Zotelli, Cássia Maria Grillo, Maria da Luz Rosário de Sousa. (2014) Nausea Control by Needling at Acupuncture Point Neiguan (PC6) During an Intraoral Impression-Taking Procedure. Journal of Acupuncture and Meridian Studies
    CrossRef

  55. 55

    R. Forestier, C. Genty, B. Waller, A. Françon, H. Desfour, C. Rolland, C.-F. Roques, J.-L. Bosson. (2014) Crenobalneotherapy (spa therapy) in patients with knee and generalized osteoarthritis: A post-hoc subgroup analysis of a large multicentre randomized trial. Annals of Physical and Rehabilitation Medicine 57, 213-227
    CrossRef

  56. 56

    Ulkine Bingel. (2014) Placeboeffekte und ihre Implikationen in der Medizin. Uro-News 18, 34-44
    CrossRef

  57. 57

    Mark Plazier, Ingrid Dekelver, Sven Vanneste, Gaëtane Stassijns, Tomas Menovsky, Mark Thimineur, Dirk De Ridder. (2014) Occipital Nerve Stimulation in Fibromyalgia: A Double-Blind Placebo-Controlled Pilot Study With a Six-Month Follow-Up. Neuromodulation: Technology at the Neural Interface 17:10.1111/ner.2014.17.issue-3, 256-264
    CrossRef

  58. 58

    A. Gold, P. Lichtenberg. (2014) The moral case for the clinical placebo. Journal of Medical Ethics 40, 219-224
    CrossRef

  59. 59

    Mang L. Chen, Christopher J. Chermansky, Bing Shen, James R. Roppolo, William C. de Groat, Changfeng Tai. (2014) Electrical Stimulation of Somatic Afferent Nerves in the Foot Increases Bladder Capacity in Healthy Human Subjects. The Journal of Urology 191, 1009-1013
    CrossRef

  60. 60

    Wenxun Wu, Detao Yin, Weimin Yang, Quancheng Kan, Zhangsuo Liu, Xiaoyan Ren, Chenguang Zhai, Shengjun Zhang, Wenxun Wu. . Chinese herbal medicines for benign thyroid nodules in adults. 2014.
    CrossRef

  61. 61

    Ulrike Bingel. (2014) Placebos in der Schmerztherapie. MMW - Fortschritte der Medizin 156, 81-85
    CrossRef

  62. 62

    Devdutt Nayak, Vicky Chodha. (2014) Use of Placebos Poses Ethical Dilemma. Psychiatric Annals 44, 89-93
    CrossRef

  63. 63

    Morton E. Tavel. (2014) The Placebo Effect: The Good, The Bad And The Ugly. The American Journal of Medicine
    CrossRef

  64. 64

    Dehua Li, Mingxiao Yang, Ling Zhao, Hui Zheng, Ying Li, Xiaorong Chang, Jin Cui, Ruihui Wang, Jing Shi, Junling Lv, Junyan Leng, Juan Li, Fanrong Liang. (2014) Acupuncture for chronic, stable angina pectoris and an investigation of the characteristics of acupoint specificity: study protocol for a multicenter randomized controlled trial. Trials 15, 50
    CrossRef

  65. 65

    Genrikh R. Ivanitskii, Aleksandr A. Deev, Evgenii P. Khizhnyak. (2014) Long-term dynamic structural memory in water: can it exist?. Uspekhi Fizicheskih Nauk 184, 43-74
    CrossRef

  66. 66

    L. Colloca. . Ethics of Placebos. 2014.
    CrossRef

  67. 67

    Lene Vase, Ina Skyt, Gitte Laue Petersen, Donald D. Price. (2014) Placebo and Nocebo Effects in Chronic Pain Patients. Zeitschrift für Psychologie 222, 135-139
    CrossRef

  68. 68

    Nobuya Yanai, Tomoyuki Niitsuma, Shigenobu Shiotani, Shoji Hagiwara, Hiroshi Nabetani. (2014) A Mixture of Histidine-Dipeptides, Vitamin C, and Ferulic Acid Reduces Comet Assay Scores in Normal Middle-Aged Men.. Food Science and Technology Research 20, 485-491
    CrossRef

  69. 69

    Jason P. Rose, Andrew L. Geers, Stephanie L. Fowler, Heather M. Rasinski. (2014) Choice-making, Expectations, and Treatment Positivity: How and When Choosing Shapes Aversive Experiences. Journal of Behavioral Decision Making 27:10.1002/bdm.v27.1, 1-10
    CrossRef

  70. 70

    Ulrike Bingel. (2014) Placeboeffekte und ihre Implikationen in der Neurologie. InFo Neurologie & Psychiatrie 16, 46-56
    CrossRef

  71. 71

    Wendy Rogers, Katrina Hutchison, Zoë C Skea, Marion K Campbell. (2014) Strengthening the ethical assessment of placebo-controlled surgical trials: three proposals. BMC Medical Ethics 15, 78
    CrossRef

  72. 72

    Ioannis D. Papanastassiou, Andreas Filis, Kamran Aghayev, Zinon T. Kokkalis, Maria A. Gerochristou, Frank D. Vrionis. (2014) Adverse Prognostic Factors and Optimal Intervention Time for Kyphoplasty/Vertebroplasty in Osteoporotic Fractures. BioMed Research International 2014, 1-7
    CrossRef

  73. 73

    Wilfried Tröger, Zdravko Ždrale, Nevena Tišma, Miodrag Matijašević. (2014) Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial. Evidence-Based Complementary and Alternative Medicine 2014, 1-9
    CrossRef

  74. 74

    Danielle Murray, A. Jon Stoessl. (2013) Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions. Pharmacology & Therapeutics 140, 306-318
    CrossRef

  75. 75

    Virginie Bardot, Pauline Charvy, Guillaume Airagnes, Camille Petron-Bardou, Véronique Venel, Bertrand Diquet, Philippe Lascar. (2013) L’origine du placebo. Perspectives Psy 52, 314-320
    CrossRef

  76. 76

    John C. Licciardone, Cathleen M. Kearns, Dennis E. Minotti. (2013) Outcomes of osteopathic manual treatment for chronic low back pain according to baseline pain severity: Results from the OSTEOPATHIC Trial. Manual Therapy 18, 533-540
    CrossRef

  77. 77

    R. Norman Harden, Roy Freeman, Michelle Rainka, Lixin Zhang, Chris Bell, Alienor Berges, Chao Chen, Ole Graff, Kathleen Harding, Setrina Hunter, Sarah Kavanagh, Caryl Schwartzbach, Samantha Warren, Carrie McClung. (2013) A Phase 2a, Randomized, Crossover Trial of Gabapentin Enacarbil for the Treatment of Postherpetic Neuralgia in Gabapentin Inadequate Responders. Pain Medicine 14, 1918-1932
    CrossRef

  78. 78

    Harri Hemilä, Teija Koivula, Harri Hemilä. . Vitamin C for preventing and treating tetanus. 2013.
    CrossRef

  79. 79

    Jayne Jubb, Jozien M. Bensing. (2013) The sweetest pill to swallow: How patient neurobiology can be harnessed to maximise placebo effects. Neuroscience & Biobehavioral Reviews
    CrossRef

  80. 80

    A. Abhishek, M. Doherty. (2013) Mechanisms of the placebo response in pain in osteoarthritis. Osteoarthritis and Cartilage 21, 1229-1235
    CrossRef

  81. 81

    Diether Neubert. . Allgemeine Grundsätze der toxikologischen Risikoabschätzung und der präventiven Gefährdungsminimierung bei Lebensmitteln. 2013:, 1-74.
    CrossRef

  82. 82

    I. Matok, J. Umans, M. N. Feghali, S. Clark, S. Caritis, M. Miodovnik, G. Hankins, D. R. Mattison, H. Nordeng, G. Koren. (2013) Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial. Journal of Obstetrics and Gynaecology 33, 557-560
    CrossRef

  83. 83

    E. Kamenica, R. Naclerio, A. Malani. (2013) Advertisements impact the physiological efficacy of a branded drug. Proceedings of the National Academy of Sciences
    CrossRef

  84. 84

    Paul Biegler. (2013) Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising. Journal of Business Ethics
    CrossRef

  85. 85

    Johan Verhulst, Douglas Kramer, Alan C. Swann, Barbara Hale-Richlen, John Beahrs. (2013) The Medical Alliance. The Journal of Nervous and Mental Disease 201, 546-552
    CrossRef

  86. 86

    Emanuel Severus, Ilya Lipkovich, Florian Seemüller, Michael Obermeier, Heinz Grunze, Britta Bernhard, Sandra Dittmann, Michael Riedel, Hans-Jürgen Möller. (2013) The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice. The World Journal of Biological Psychiatry 14, 386-395
    CrossRef

  87. 87

    Anne Holbrook, Charles H. Goldsmith, Mova Leung. . Placebos. 2013.
    CrossRef

  88. 88

    Álvaro Sanz, Maku Zudaire, Begoña Morejón, Virginia de la Cruz, Itziar Gardeazabal, José María López-Picazo, María Luisa del Valle, Carlos Centeno. (2013) Cómo responder al paciente con cáncer avanzado que nos plantea el uso de cannabis como tratamiento sintomático. Medicina Paliativa
    CrossRef

  89. 89

    Jose M. Fernandez. (2013) AN EMPIRICAL MODEL OF LEARNING UNDER AMBIGUITY: THE CASE OF CLINICAL TRIALS*. International Economic Review 54:10.1111/iere.2013.54.issue-2, 549-573
    CrossRef

  90. 90

    Paul Dieppe. (2013) Trial designs and exploration of the placebo response. Complementary Therapies in Medicine 21, 105-108
    CrossRef

  91. 91

    Irving Kirsch. (2013) The placebo effect revisited: Lessons learned to date. Complementary Therapies in Medicine 21, 102-104
    CrossRef

  92. 92

    Marta Peciña, Hamdan Azhar, Tiffany M Love, Tingting Lu, Barbara L Fredrickson, Christian S Stohler, Jon-Kar Zubieta. (2013) Personality Trait Predictors of Placebo Analgesia and Neurobiological Correlates. Neuropsychopharmacology 38, 639-646
    CrossRef

  93. 93

    Ian M. Handley, Stephanie L. Fowler, Heather M. Rasinski, Suzanne G. Helfer, Andrew L. Geers. (2013) Beliefs About Expectations Moderate the Influence of Expectations on Pain Perception. International Journal of Behavioral Medicine 20, 52-58
    CrossRef

  94. 94

    Tal Shahar, Uri Rozovski, Zvi Ram. (2013) Does enrollment in a trial carry a survival advantage for patients?. Clinical Investigation 3, 219-221
    CrossRef

  95. 95

    Pascal-Henri Keller, Annie Giroux-Gonon, François Gonon. (2013) Effet placebo et antidépresseurs : une revue de la littérature éclairée par la psychanalyse. L'Évolution Psychiatrique
    CrossRef

  96. 96

    Andrea Bradford. (2013) Listening to Placebo in Clinical Trials for Female Sexual Dysfunction. The Journal of Sexual Medicine 10, 451-459
    CrossRef

  97. 97

    Hongliang Zhang. . Ethical Use of Placebo in Research and Practice. 2013.
    CrossRef

  98. 98

    Harald Walach. . Placebo Effects in Complementary and Alternative Medicine. 2013:, 189-202.
    CrossRef

  99. 99

    Luana Colloca, Franklin G. Miller. . Placebo and Nocebo. 2013:, 277-286.
    CrossRef

  100. 100

    D Knapp van Bogaert, GA Ogunbanjo. (2013) The ethics of placebos. South African Family Practice 55, S15-S16
    CrossRef

  101. 101

    Lene Vase, Gitte Laue Petersen. . Conceptualizations and Magnitudes of Placebo Analgesia Effects Across Meta-Analyses and Experimental Studies. 2013:, 203-213.
    CrossRef

  102. 102

    Magne Arve Flaten, Per M. Aslaksen, Peter S. Lyby. . Positive and Negative Emotions and Placebo Analgesia. 2013:, 73-81.
    CrossRef

  103. 103

    Paul Enck, Katja Weimer, Sibylle Klosterhalfen. . Balanced Placebo Design, Active Placebos, and Other Design Features for Identifying, Minimizing and Characterizing the Placebo Response. 2013:, 159-173.
    CrossRef

  104. 104

    Francisco Tausk, Robert Ader, Nana Duffy (Smith). (2013) The placebo effect: Why we should care. Clinics in Dermatology 31, 86-91
    CrossRef

  105. 105

    Damien Finniss. . Historical Aspects of Placebo Analgesia. 2013:, 1-8.
    CrossRef

  106. 106

    Magne Arve Flaten, Karin Meissner, Luana Colloca. . Methodologic Aspects of Placebo Research. 2013:, 149-157.
    CrossRef

  107. 107

    David Beckwée, Peter Vaes, Maarten Cnudde, Eva Swinnen, Ivan Bautmans. (2013) Osteoarthritis of the knee: Why does exercise work? A qualitative study of the literature. Ageing Research Reviews 12, 226-236
    CrossRef

  108. 108

    Edward Tobinick, Nancy M. Kim, Gary Reyzin, Helen Rodriguez-Romanacce, Venita DePuy. (2012) Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury. CNS Drugs 26, 1051-1070
    CrossRef

  109. 109

    Boadie W Dunlop, Michael E Thase, Chuan-Chuan Wun, Rana Fayyad, Christine J Guico-Pabia, Jeff Musgnung, Philip T Ninan. (2012) A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites. Neuropsychopharmacology 37, 2830-2836
    CrossRef

  110. 110

    Amanda C de C Williams, Christopher Eccleston, Stephen Morley, Amanda C de C Williams. . Psychological therapies for the management of chronic pain (excluding headache) in adults. 2012.
    CrossRef

  111. 111

    D.P. Touwen, D.P. Engberts. (2012) Those famous red pills—Deliberations and hesitations. Ethics of placebo use in therapeutic and research settings. European Neuropsychopharmacology 22, 775-781
    CrossRef

  112. 112

    Mark J DiNubile, Peter Sklar, Robert J Lupinacci, Joseph J Eron Jr. (2012) Paradoxical interpretations of noninferiority studies: violating the excluded middle. Future Virology 7, 1055-1063
    CrossRef

  113. 113

    Sonia A. Lamel, Kaley A. Myer, Naji Younes, James A. Zhou, Hilda Maibach, Howard I. Maibach. (2012) Placebo response in relation to clinical trial design: a systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment. Archives of Dermatological Research 304, 707-717
    CrossRef

  114. 114

    Mei-Ling Yeh, Yu-Ling Hung, Hsing-Hsia Chen, Yu-Jen Wang. (2012) Auricular Acupressure for Pain Relief in Adolescents with Dysmenorrhea: A Placebo-Controlled Study. The Journal of Alternative and Complementary Medicine, 121106061520008
    CrossRef

  115. 115

    Jayasri Srinivasan, Sarah Lidstone, Raúl de la Fuente-Fernández, A Stoessl. . Placebo Effect in Parkinson’s Disease. 2012:, 803-810.
    CrossRef

  116. 116

    Ioannis D. Papanastassiou, Frank M. Phillips, Jan Meirhaeghe, James R. Berenson, Gunnar B. J. Andersson, Gary Chung, Brent J. Small, Kamran Aghayev, Frank D. Vrionis. (2012) Comparing effects of kyphoplasty, vertebroplasty, and non-surgical management in a systematic review of randomized and non-randomized controlled studies. European Spine Journal 21, 1826-1843
    CrossRef

  117. 117

    Willem Krol. (2012) Effecten van extra water drinken bij hoofdpijn. Huisarts en wetenschap 55, 375-375
    CrossRef

  118. 118

    Jason P. Rose, Andrew L. Geers, Heather M. Rasinski, Stephanie L. Fowler. (2012) Choice and placebo expectation effects in the context of pain analgesia. Journal of Behavioral Medicine 35, 462-470
    CrossRef

  119. 119

    Hugh MacPherson, Richard Hammerschlag. (2012) Acupuncture and the Emerging Evidence Base: Contrived Controversy and Rational Debate. Journal of Acupuncture and Meridian Studies 5, 141-147
    CrossRef

  120. 120

    Sven Vanneste, Dirk De Ridder. (2012) Noninvasive and Invasive Neuromodulation for the Treatment of Tinnitus: An Overview. Neuromodulation: Technology at the Neural Interface 15:10.1111/ner.2012.15.issue-4, 350-360
    CrossRef

  121. 121

    Katherine B. Knox, Michael E. Kelly. (2012) Placebo Power. Techniques in Vascular and Interventional Radiology 15, 150-152
    CrossRef

  122. 122

    Anne Barnhill. (2012) Clinical Use of Placebos: Still the Physician's Prerogative?. Hastings Center Report 42:10.1002/hast.2012.42.issue-3, 29-37
    CrossRef

  123. 123

    Andrew Turner. (2012) ‘Placebos’ and the logic of placebo comparison. Biology & Philosophy 27, 419-432
    CrossRef

  124. 124

    Katrina Williams, John A Wray, Danielle M Wheeler, Katrina Williams. . Intravenous secretin for autism spectrum disorders (ASD). 2012.
    CrossRef

  125. 125

    A. Autret, D. Valade, S. Debiais. (2012) Placebo and other psychological interactions in headache treatment. The Journal of Headache and Pain 13, 191-198
    CrossRef

  126. 126

    Lauren Y. Atlas, Tor D. Wager. (2012) How expectations shape pain. Neuroscience Letters
    CrossRef

  127. 127

    Dan Shan, Hong Mei Wu, Qi Yuan Yuan, Jun Li, Rong Le Zhou, Guan J Liu, Hong Mei Wu. . Pentoxifylline for diabetic kidney disease. 2012.
    CrossRef

  128. 128

    Deusvenir de Souza Carvalho, Liselotte Menke Barea, Pedro André Kowacs, Yara Dadalti Fragoso. (2012) Efficacy and tolerability of combined dipyrone, isometheptene and caffeine in the treatment of mild-to-moderate primary headache episodes. Expert Review of Neurotherapeutics 12, 159-167
    CrossRef

  129. 129

    H P Rang, M M Dale, J M Ritter, R J Flower, G Henderson. . Method and measurement in pharmacology. 2012:, 89-98.
    CrossRef

  130. 130

    Andrew L Avins, Daniel C Cherkin, Karen J Sherman, Harley Goldberg, Alice Pressman. (2012) Should we reconsider the routine use of placebo controls in clinical research?. Trials 13, 44
    CrossRef

  131. 131

    K. Linde, YH Koog, SR We, BI Min. (2012) Three-armed trials including placebo and no-treatment groups may be subject to publication bias: systematic review. Deutsche Zeitschrift für Akupunktur 55, 24-25
    CrossRef

  132. 132

    Philippe P. Hujoel. . Assessing Evidence. 2012:, 768.e17-768.e28.
    CrossRef

  133. 133

    Sarah Malek, Susannah J Sample, Zeev Schwartz, Brett Nemke, Peer B Jacobson, Elizabeth M Cozzi, Susan L Schaefer, Jason A Bleedorn, Gerianne Holzman, Peter Muir. (2012) Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis. BMC Veterinary Research 8, 185
    CrossRef

  134. 134

    Melvin L. Morse, Lance W. Beem. (2011) Benefits of Reiki Therapy for a Severely Neutropenic Patient with Associated Influences on a True Random Number Generator. The Journal of Alternative and Complementary Medicine, 111201124637009
    CrossRef

  135. 135

    Patricia Wheaton, Jane L. Mathias, Robert Vink. (2011) Impact of Pharmacological Treatments on Cognitive and Behavioral Outcome in the Postacute Stages of Adult Traumatic Brain Injury. Journal of Clinical Psychopharmacology 31, 745-757
    CrossRef

  136. 136

    J.-P. Lefaucheur, N. André-Obadia, E. Poulet, H. Devanne, E. Haffen, A. Londero, B. Cretin, A.-M. Leroi, A. Radtchenko, G. Saba, H. Thai-Van, C.-F. Litré, L. Vercueil, D. Bouhassira, S.-S. Ayache, W.-H. Farhat, H.-G. Zouari, V. Mylius, M. Nicolier, L. Garcia-Larrea. (2011) Recommandations françaises sur l’utilisation de la stimulation magnétique transcrânienne répétitive (rTMS) : règles de sécurité et indications thérapeutiques. Neurophysiologie Clinique/Clinical Neurophysiology 41, 221-295
    CrossRef

  137. 137

    Asbjørn Hróbjartsson, Ted J. Kaptchuk, Franklin G. Miller. (2011) Placebo effect studies are susceptible to response bias and to other types of biases. Journal of Clinical Epidemiology 64, 1223-1229
    CrossRef

  138. 138

    A Hróbjartsson, I Boutron. (2011) Blinding in Randomized Clinical Trials: Imposed Impartiality. Clinical Pharmacology & Therapeutics 90, 732-736
    CrossRef

  139. 139

    Karolina Wartolowska. (2011) How neuroimaging can help us to visualise and quantify pain?. European Journal of Pain Supplements 5, 323-327
    CrossRef

  140. 140

    Phyllis Zelkowitz, Nancy Feeley, Ian Shrier, Robyn Stremler, Ruta Westreich, David Dunkley, Russell Steele, Zeev Rosberger, Francine Lefebvre, Apostolos Papageorgiou. (2011) The Cues and Care Randomized Controlled Trial of a Neonatal Intensive Care Unit Intervention: Effects on Maternal Psychological Distress and Mother-Infant Interaction. Journal of Developmental & Behavioral Pediatrics 32, 591-599
    CrossRef

  141. 141

    Tuomas K. Pernu. (2011) Minding matter: how not to argue for the causal efficacy of the mental. Reviews in the Neurosciences 22, 483-507
    CrossRef

  142. 142

    Annette van Maanen, Anne Marie Meijer, Marcel G. Smits, Frans J. Oort. (2011) Termination of short term melatonin treatment in children with delayed Dim Light Melatonin Onset: Effects on sleep, health, behavior problems, and parenting stress. Sleep Medicine 12, 875-879
    CrossRef

  143. 143

    Per E. Wändell, Axel C. Carlsson, Catharina Gåfvels, Katarina Andersson, Lena Törnkvist. (2011) Measuring possible effect on health-related quality of life by tactile massage or relaxation in patients with type 2 diabetes. Complementary Therapies in Medicine
    CrossRef

  144. 144

    Atsushi Hashizume, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Noriaki Suga, Fumiaki Tanaka, Gen Sobue. (2011) Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. Journal of Neurology
    CrossRef

  145. 145

    Joram Ronel, Julinda Mehilli, Karl-Heinz Ladwig, Hannah Blättler, Nina Oversohl, Robert A. Byrne, Axel Bauer, Simon Schneider, Klaus Linde, Peter Henningsen, Claas Lahmann, Michael Noll-Hussong, Karin Meissner. (2011) Effects of verbal suggestion on coronary arteries: Results of a randomized controlled experimental investigation during coronary angiography. American Heart Journal 162, 507-511
    CrossRef

  146. 146

    Paul Enck, Bjoern Horing, Katja Weimer, Sibylle Klosterhalfen. (2011) Placebo responses and placebo effects in functional bowel disorders. European Journal of Gastroenterology & Hepatology, 1
    CrossRef

  147. 147

    Stephen Senn. (2011) Francis Galton and regression to the mean. Significance 8, 124-126
    CrossRef

  148. 148

    Donald A. Redelmeier, Victoria M. Dickinson. (2011) Determining Whether a Patient is Feeling Better: Pitfalls from the Science of Human Perception. Journal of General Internal Medicine 26, 900-906
    CrossRef

  149. 149

    Paul Arnstein, Kathleen Broglio, Elsa Wuhrman. (2011) El placebo no tiene cabida en el tratamiento del dolor. Nursing (Ed. española) 29, 36-37
    CrossRef

  150. 150

    J. Pearce. (2011) The placebo enigma revisited. Clinical Medicine 11, 340-343
    CrossRef

  151. 151

    Sanjay Rajagopalan, Georgeta Mihai. (2011) Perspectives on Optimizing Trial Design and Endpoints in Peripheral Arterial Disease: A Case for Imaging-Based Surrogates as Endpoints of Functional Efficacy. Cardiology Clinics 29, 419-431
    CrossRef

  152. 152

    Herand Abcarian. (2011) Routine Antibiotics for Anorectal Abscess: The Answer Is Still No. Diseases of the Colon & Rectum 54, 917-918
    CrossRef

  153. 153

    Wechsler , Michael E. , Kelley , John M. , Boyd , Ingrid O.E. , Dutile , Stefanie , Marigowda , Gautham , Kirsch , Irving , Israel , Elliot , Kaptchuk , Ted J. (2011) Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma. New England Journal of Medicine 365:2, 119-126
    Free Full Text

  154. 154

    Altaf Mangera, Christopher R. Chapple, Zoe S. Kopp, Melanie Plested. (2011) The placebo effect in overactive bladder syndrome. Nature Reviews Urology 8, 495-503
    CrossRef

  155. 155

    Rémy Boussageon. (2011) The placebo effect: Still under a cloud of confusion. Comments on the update by J.-M. Berthelot. Joint Bone Spine 78, 433
    CrossRef

  156. 156

    Chin-wern Chan, Philip W.H. Peng. (2011) Suprascapular Nerve Block. Regional Anesthesia and Pain Medicine 36, 358-373
    CrossRef

  157. 157

    Simon R. Brice, Brett S. Jarosz, Rick A. Ames, James Baglin, Cliff Da Costa. (2011) The effect of close proximity holographic wristbands on human balance and limits of stability: A randomised, placebo-controlled trial. Journal of Bodywork and Movement Therapies 15, 298-303
    CrossRef

  158. 158

    Jean-Marie Berthelot. (2011) Response to the comment by Rémy Boussageon (The placebo effect: Still under a cloud of confusion) on the article by Berthelot et al. (The placebo effect in rheumatology). Joint Bone Spine 78, 433-434
    CrossRef

  159. 159

    M. S. Mora, Y. Nestoriuc, W. Rief. (2011) Lessons learned from placebo groups in antidepressant trials. Philosophical Transactions of the Royal Society B: Biological Sciences 366, 1879-1888
    CrossRef

  160. 160

    L. Colloca, F. G. Miller. (2011) Harnessing the placebo effect: the need for translational research. Philosophical Transactions of the Royal Society B: Biological Sciences 366, 1922-1930
    CrossRef

  161. 161

    K. Linde, M. Fassler, K. Meissner. (2011) Placebo interventions, placebo effects and clinical practice. Philosophical Transactions of the Royal Society B: Biological Sciences 366, 1905-1912
    CrossRef

  162. 162

    K. Meissner. (2011) The placebo effect and the autonomic nervous system: evidence for an intimate relationship. Philosophical Transactions of the Royal Society B: Biological Sciences 366, 1808-1817
    CrossRef

  163. 163

    Jack Coulehan. (2011) Deep hope: A song without words. Theoretical Medicine and Bioethics 32, 143-160
    CrossRef

  164. 164

    Atsushi Ogawa, Shiro Hinotsu, Hisashi Urushihara, Koji Kawakami. (2011) Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration. Sleep Medicine 12, 565-571
    CrossRef

  165. 165

    Andrew L. Geers, Justin A. Wellman, Stephanie L. Fowler, Heather M. Rasinski, Suzanne G. Helfer. (2011) Placebo expectations and the detection of somatic information. Journal of Behavioral Medicine 34, 208-217
    CrossRef

  166. 166

    Eric Manheimer. (2011) Selecting a control for in vitro fertilization and acupuncture randomized controlled trials (RCTs): how sham controls may unnecessarily complicate the RCT evidence base. Fertility and Sterility 95, 2456-2461
    CrossRef

  167. 167

    Nathalie André-Obadia, Michel Magnin, Luis Garcia-Larrea. (2011) On the importance of placebo timing in rTMS studies for pain relief. Pain 152, 1233-1237
    CrossRef

  168. 168

    Michael P. Murphy, Jeffrey H. Lawson, Brian M. Rapp, Michael C. Dalsing, Janet Klein, Michael G. Wilson, Gary D. Hutchins, Keith L. March. (2011) Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. Journal of Vascular Surgery 53, 1565-1574.e1
    CrossRef

  169. 169

    John E. O'Toole, Vincent C. Traynelis. (2011) Editorial: Vertebral compression fractures. Journal of Neurosurgery: Spine 14, 555-560
    CrossRef

  170. 170

    Kenneth E. Freedland, David C. Mohr, Karina W. Davidson, Joseph E. Schwartz. (2011) Usual and Unusual Care. Psychosomatic Medicine 73, 323-335
    CrossRef

  171. 171

    J. Corfmat, D. Januel, S. Braha, V. Moulier. (2011) L’effet placebo : généralités et spécificités en psychiatrie (dépression et schizophrénie). L'Encéphale
    CrossRef

  172. 172

    Clifford Gevirtz. (2011) Placebo and Nocebo. Topics in Pain Management 26, 1-6
    CrossRef

  173. 173

    D. Corydon Hammond. (2011) Placebos and Neurofeedback: A Case for Facilitating and Maximizing Placebo Response in Neurofeedback Treatments. Journal of Neurotherapy 15, 94-114
    CrossRef

  174. 174

    References. 2011:, 193-223.
    CrossRef

  175. 175

    Majid Reza Farrokhi, Ehsanali Alibai, Zohre Maghami. (2011) Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery: Spine, 1-9
    CrossRef

  176. 176

    Paul Arnstein, Kathleen Broglio, Elsa Wuhrman, Mary Beth Kean. (2011) Use of Placebos in Pain Management. Pain Management Nursing
    CrossRef

  177. 177

    Jean-Marie Berthelot. (2011) The placebo effect in rheumatology: New data. Joint Bone Spine 78, 161-165
    CrossRef

  178. 178

    Qing Zhao, Zhi-hong Liu, Qin Luo, Zhi-hui Zhao, Hong-liang Zhang, Yong Wang. (2011) Effects of continuous positive airway pressure on blood pressure and daytime sleepiness in obstructive sleep apnea patients with coronary heart diseases under optimal medications. Sleep and Breathing
    CrossRef

  179. 179

    Bruce J Kinon, Alison J Potts, Susan B Watson. (2011) Placebo response in clinical trials with schizophrenia patients. Current Opinion in Psychiatry, 1
    CrossRef

  180. 180

    S. McGuirk, C. Fahy, D. Costi, A. M. Cyna. (2011) Use of invasive placebos in research on local anaesthetic interventions. Anaesthesia 66:10.1111/anae.2011.66.issue-2, 84-91
    CrossRef

  181. 181

    Richard L. Kradin. (2011) Placebo Response: A Consideration of its Role in Therapeutics. Current Psychiatry Reports 13, 37-42
    CrossRef

  182. 182

    Andrew J Hahne, Jon J Ford, Luke D Surkitt, Matthew C Richards, Alexander YP Chan, Sarah L Thompson, Rana S Hinman, Nicholas F Taylor. (2011) Specific treatment of problems of the spine (STOPS): design of a randomised controlled trial comparing specific physiotherapy versus advice for people with subacute low back disorders. BMC Musculoskeletal Disorders 12, 104
    CrossRef

  183. 183

    John C. Longhurst, Rebecca B. Costello. . Integrative Medicine in the Prevention of Cardiovascular Disease. 2011:, 272-299.
    CrossRef

  184. 184

    Jean-Marie Berthelot. (2011) L’effet placebo en rhumatologie : des nouveautés. Revue du Rhumatisme 78, 32-36
    CrossRef

  185. 185

    Henning Zeidler. (2011) Paracetamol and the Placebo Effect in Osteoarthritis Trials: A Missing Link?. Pain Research and Treatment 2011, 1-6
    CrossRef

  186. 186

    Paul Arnstein, Kathleen Broglio, Elsa Wuhrman. (2011) Placebos. Nursing 41, 66-67
    CrossRef

  187. 187

    Ulrike Bingel, Luana Colloca, Lene Vase. (2011) Mechanisms and Clinical Implications of the Placebo Effect: Is There a Potential for the Elderly? A Mini-Review. Gerontology 57, 354-363
    CrossRef

  188. 188

    Karen Wager-Smith, Athina Markou. (2011) Depression: A repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?. Neuroscience & Biobehavioral Reviews 35, 742-764
    CrossRef

  189. 189

    Rob Herbert, Gro Jamtvedt, Kåre Birger Hagen, Judy Mead. . Can I trust this evidence?. 2011:, 61-92.
    CrossRef

  190. 190

    Maurizio Marogna, Igino Spadolini, Alessandro Massolo, Giorgio Walter Canonica, Giovanni Passalacqua. (2010) Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. Journal of Allergy and Clinical Immunology 126, 969-975
    CrossRef

  191. 191

    Paul Enck, Sibylle Klosterhalfen, Stephan Zipfel. (2010) Acupuncture, psyche and the placebo response. Autonomic Neuroscience 157, 68-73
    CrossRef

  192. 192

    Yukitoshi Aoyagi, Hyuntae Park, Sungjin Park, Kazuhiro Yoshiuchi, Hiroe Kikuchi, Hiroshi Kawakami, Yoshikazu Morita, Aiko Ono, Roy J. Shephard. (2010) Interactive effects of milk basic protein supplements and habitual physical activity on bone health in older women: A 1-year randomized controlled trial. International Dairy Journal 20, 724-730
    CrossRef

  193. 193

    George Philip, Arlene S. Swern, Steven S. Smugar, David S. Pearlman. (2010) Baseline Predictors of Placebo Response in Exercise-Induced Bronchoconstriction (EIB): Pooled Regression Analysis >From Three Studies of Montelukast in EIB. Journal of Asthma 47, 935-941
    CrossRef

  194. 194

    Jozien M. Bensing, William Verheul. (2010) The silent healer: The role of communication in placebo effects. Patient Education and Counseling 80, 293-299
    CrossRef

  195. 195

    MH Pittler, JL Bosson. (2010) Spa therapy for knee osteoarthritis - a fair test?. Focus on Alternative and Complementary Therapies 15, 257-258
    CrossRef

  196. 196

    Matthias Breidert, Karl Hofbauer. (2010) Placebo: Missverständnisse und Vorurteile. Osteopathische Medizin 11, 14-18
    CrossRef

  197. 197

    Thomas J Povsic, Christopher M O’Connor. (2010) Cell therapy for heart failure: the need for a new therapeutic strategy. Expert Review of Cardiovascular Therapy 8, 1107-1126
    CrossRef

  198. 198

    Henda Foreid, Carla Bentes, José Pimentel. (2010) The Use of Placebo as a Provocative Test in the Diagnosis of Psychogenic Non Epileptic Seizures. Neuroethics 3, 95-98
    CrossRef

  199. 199

    Roy La Touche, Greg Goddard, José Luis De-la-Hoz, Kelun Wang, Alba Paris-Alemany, Santiago Angulo-Díaz-Parreño, Juan Mesa, Mar Hernández. (2010) Acupuncture in the Treatment of Pain in Temporomandibular Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The Clinical Journal of Pain 26, 541-550
    CrossRef

  200. 200

    Jens Foell. (2010) Is electro-acupuncture a safe and cost-effective treatment for Achilles tendonopathy in a primary care setting?. International Musculoskeletal Medicine 32, 51-54
    CrossRef

  201. 201

    K.L. Bennell, M.A. Hunt, T.V. Wrigley, D.J. Hunter, F.J. McManus, P.W. Hodges, L. Li, R.S. Hinman. (2010) Hip strengthening reduces symptoms but not knee load in people with medial knee osteoarthritis and varus malalignment: a randomised controlled trial. Osteoarthritis and Cartilage 18, 621-628
    CrossRef

  202. 202

    U. Bingel. (2010) Mechanismen der endogenen Schmerzmodulation am Beispiel der Placeboanalgesie. Der Schmerz 24, 122-129
    CrossRef

  203. 203

    e. kokkotou, l. a. conboy, d.c. ziogas, m. t. quilty, j. m. kelley, r. b. davis, a. j. lembo, t. j. kaptchuk. (2010) Serum correlates of the placebo effect in irritable bowel syndrome. Neurogastroenterology & Motility 22:10.1111/nmo.2010.22.issue-3, 285-e81
    CrossRef

  204. 204

    Felipe Fregni, Marta Imamura, Hsin Fen Chien, Henry L. Lew, Paulo Boggio, Ted J. Kaptchuk, Marcelo Riberto, Wu Tu Hsing, Linamara Rizzo Battistella, Andrea Furlan. (2010) Challenges and Recommendations for Placebo Controls in Randomized Trials in Physical and Rehabilitation Medicine. American Journal of Physical Medicine & Rehabilitation 89, 160-172
    CrossRef

  205. 205

    E Paul Cherniack. (2010) Would the elderly be better off if they were given more placebos?. Geriatrics & Gerontology International
    CrossRef

  206. 206

    Maxine de la Cruz, David Hui, Henrique A. Parsons, Eduardo Bruera. (2010) Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 116:10.1002/cncr.v116:3, 766-774
    CrossRef

  207. 207

    Mariangela Rondanelli, Attilio Giacosa, Annalisa Opizzi, Claudio Pelucchi, Carlo La Vecchia, Gigliola Montorfano, Manuela Negroni, Bruno Berra, Pierluigi Politi, Angela Maria Rizzo. (2010) Effect of Omega-3 Fatty Acids Supplementation on Depressive Symptoms and on Health-Related Quality of Life in the Treatment of Elderly Women with Depression: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Journal of the American College of Nutrition 29, 55-64
    CrossRef

  208. 208

    Damien G Finniss, Ted J Kaptchuk, Franklin Miller, Fabrizio Benedetti. (2010) Biological, clinical, and ethical advances of placebo effects. The Lancet 375, 686-695
    CrossRef

  209. 209

    Philip D Shenefelt. (2010) Update on psychodermatological disorders. Expert Review of Dermatology 5, 95-107
    CrossRef

  210. 210

    Rebecca Y. Steer, Emory University, Lorie A. Ritschel. . Placebo. 2010.
    CrossRef

  211. 211

    Eric Manheimer, Ke Cheng, Klaus Linde, Lixing Lao, Junghee Yoo, Susan Wieland, Daniëlle AWM van der Windt, Brian M Berman, Lex M Bouter, Eric Manheimer. . Acupuncture for peripheral joint osteoarthritis. 2010.
    CrossRef

  212. 212

    Asbjørn Hróbjartsson, Peter C Gøtzsche, Asbjørn Hróbjartsson. . Placebo interventions for all clinical conditions. 2010.
    CrossRef

  213. 213

    W. C. GALLAHAN, D. CASE, R. S. BLOOMFELD. (2010) An analysis of the placebo effect in Crohnâs disease over time. Alimentary Pharmacology & Therapeutics 31:10.1111/apt.2009.31.issue-1, 102-107
    CrossRef

  214. 214

    A.B. Guekht, A.D. Korczyn, I.B. Bondareva, E.I. Gusev. (2010) Placebo responses in randomized trials of antiepileptic drugs. Epilepsy & Behavior 17, 64-69
    CrossRef

  215. 215

    K. Linde, Matias Vested Madsen, Peter C. Gøtzsche, Asbjørn Hrobjartsson. (2010) Acupuncture Treatment for Pain: Systematic Review of Randomised Clinical Trials with Acupuncture, Placebo Acupuncture, and no Acupuncture Groups. Deutsche Zeitschrift für Akupunktur 53, 40-41
    CrossRef

  216. 216

    Robert W. Hurley, Christopher L. Wu. . Acute Postoperative Pain. 2010:, 2757-2781.
    CrossRef

  217. 217

    Hsueh-Chieh Lu, Jen-Chuen Hsieh, Ching-Liang Lu, David M. Niddam, Yu-Te Wu, Tzu-Chen Yeh, Chou-Ming Cheng, Full-Young Chang, Shou-Dong Lee. (2010) Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: A 3T-fMRI study. Pain 148, 75-83
    CrossRef

  218. 218

    Mark T. Osterman, Gary R. Lichtenstein. . Ulcerative Colitis. 2010:, 1975-2013.e9.
    CrossRef

  219. 219

    Kavita R. Shah, Susan Dorr Goold. (2009) The Primacy of Autonomy, Honesty, and Disclosure—Council on Ethical and Judicial Affairs' Placebo Opinions. The American Journal of Bioethics 9, 15-17
    CrossRef

  220. 220

    Bennett Foddy. (2009) A Duty to Deceive: Placebos in Clinical Practice. The American Journal of Bioethics 9, 4-12
    CrossRef

  221. 221

    Franklin G. Miller, Luana Colloca. (2009) The Legitimacy of Placebo Treatments in Clinical Practice: Evidence and Ethics. The American Journal of Bioethics 9, 39-47
    CrossRef

  222. 222

    Daniela Lucini, Mara Malacarne, Nadia Solaro, Silvano Busin, Massimo Pagani. (2009) Complementary medicine for the management of chronic stress: superiority of active versus passive techniques. Journal of Hypertension 27, 2421-2428
    CrossRef

  223. 223

    F. J. GIANOLA. (2009) The ethics of using placebos for diagnosis and treatment in clinical practice. Journal of the American Academy of Physician Assistants 22, 58-59
    CrossRef

  224. 224

    Artur Carvalho De Araujo, Fernando Gomes Da Silva, Fernando Salvi, Monique Carvalho Awad, Eloísio Alexsandro Da Silva, Ronaldo Damião. (2009) The Management of Erectile Dysfunction with Placebo Only: Does it Work?. The Journal of Sexual Medicine 6, 3440-3448
    CrossRef

  225. 225

    Winfried Rief, Yvonne Nestoriuc, Sarah Weiss, Eva Welzel, Arthur J. Barsky, Stefan G. Hofmann. (2009) Meta-analysis of the placebo response in antidepressant trials. Journal of Affective Disorders 118, 1-8
    CrossRef

  226. 226

    Mei-Chi Hsu, Hsiu-Wen Chen, Yueh-Juen Hwu, Chin-Mu Chanc, Chi-Feng Liu. (2009) Effects of thermal therapy on uremic pruritus and biochemical parameters in patients having haemodialysis. Journal of Advanced Nursing 65:10.1111/jan.2009.65.issue-11, 2397-2408
    CrossRef

  227. 227

    Lauren Y. Atlas, Tor D. Wager, Katharine P. Dahl, Edward E. Smith. . Placebo Effects. 2009.
    CrossRef

  228. 228

    Yun-Hai Qiu, Xin-Yin Wu, Hao Xu, David Sackett. (2009) Neuroimaging study of placebo analgesia in humans. Neuroscience Bulletin 25, 277-282
    CrossRef

  229. 229

    Yun Hyung Koog, Byung-Il Min. (2009) Does Random Participant Assignment Cause Fewer Benefits in Research Participants? Systematic Review of Partially Randomized Acupuncture Trials. The Journal of Alternative and Complementary Medicine 15, 1107-1113
    CrossRef

  230. 230

    Chung-Yee Cecilia Ho, Gisela Sole, Joanne Munn. (2009) The effectiveness of manual therapy in the management of musculoskeletal disorders of the shoulder: A systematic review. Manual Therapy 14, 463-474
    CrossRef

  231. 231

    M. Doherty, P. Dieppe. (2009) The “placebo” response in osteoarthritis and its implications for clinical practice. Osteoarthritis and Cartilage 17, 1255-1262
    CrossRef

  232. 232

    Stephen Senn. (2009) Placebo Misconceptions. The American Journal of Bioethics 9, 53-54
    CrossRef

  233. 233

    John M. Kelley, Anthony J. Lembo, J Stuart Ablon, Joel J. Villanueva, Lisa A. Conboy, Ray Levy, Carl D. Marci, Catherine E. Kerr, Irving Kirsch, Eric E. Jacobson, Helen Riess, Ted J. Kaptchuk. (2009) Patient and Practitioner Influences on the Placebo Effect in Irritable Bowel Syndrome. Psychosomatic Medicine 71, 789-797
    CrossRef

  234. 234

    Ted J. Kaptchuk, Jessica Shaw, Catherine E. Kerr, Lisa A. Conboy, John M. Kelley, Thomas J. Csordas, Anthony J. Lembo, Eric E. Jacobson. (2009) “Maybe I Made Up the Whole Thing”: Placebos and Patients’ Experiences in a Randomized Controlled Trial. Culture, Medicine, and Psychiatry 33, 382-411
    CrossRef

  235. 235

    Lene Vase, Gitte Laue Petersen, Joseph L. Riley, Donald D. Price. (2009) Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain 145, 36-44
    CrossRef

  236. 236

    Kallmes , David F. , Comstock , Bryan A. , Heagerty , Patrick J. , Turner , Judith A. , Wilson , David J. , Diamond , Terry H. , Edwards , Richard , Gray , Leigh A. , Stout , Lydia , Owen , Sara , Hollingworth , William , Ghdoke , Basavaraj , Annesley-Williams , Deborah J. , Ralston , Stuart H. , Jarvik , Jeffrey G. , . (2009) A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures. New England Journal of Medicine 361:6, 569-579
    Free Full Text

  237. 237

    The Relaxation System. 2009:, 131-159.
    CrossRef

  238. 238

    P. Enck, S. Zipfel, S. Klosterhalfen. (2009) Der Placeboeffekt in der Medizin. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 52, 635-642
    CrossRef

  239. 239

    Leonard S. Milling. (2009) Response expectancies: a psychological mechanism of suggested and placebo analgesia. Contemporary Hypnosis 26:10.1002/ch.v26:2, 93-110
    CrossRef

  240. 240

    Kenneth A. Holroyd, Jenifer S. Labus, Bruce Carlson. (2009) Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: The role of disorder severity and psychiatric comorbidity. Pain 143, 213-222
    CrossRef

  241. 241

    Karen L. Overall, Arthur E. Dunham. (2009) Homeopathy and the curse of the scientific method. The Veterinary Journal 180, 141-148
    CrossRef

  242. 242

    Karin Meissner. (2009) Effects of placebo interventions on gastric motility and general autonomic activity. Journal of Psychosomatic Research 66, 391-398
    CrossRef

  243. 243

    Christopher Eccleston, Amanda C de C Williams, Stephen Morley, Christopher Eccleston. . Psychological therapies for the management of chronic pain (excluding headache) in adults. 2009.
    CrossRef

  244. 244

    John M. Kelley, Patrick R. Boulos, Peter A.D. Rubin, Ted J. Kaptchuk. (2009) Mirror, mirror on the wall: placebo effects that exist only in the eye of the beholder. Journal of Evaluation in Clinical Practice 15:10.1111/jep.2009.15.issue-2, 292-298
    CrossRef

  245. 245

    Michael E. Oakes. (2009) Students’ Beliefs About Placebo Responders: Implications for Fundamentals of Psychology Courses. Current Psychology 28, 12-20
    CrossRef

  246. 246

    John R. Hughes. (2009) Ethical concerns about non-active conditions in smoking cessation trials and methods to decrease such concerns. Drug and Alcohol Dependence 100, 187-193
    CrossRef

  247. 247

    Jon-Kar Zubieta, Christian S. Stohler. (2009) Neurobiological Mechanisms of Placebo Responses. Annals of the New York Academy of Sciences 1156, 198-210
    CrossRef

  248. 248

    J. A. J. Smits, S. G. Hofmann. (2009) A meta-analytic review of the effects of psychotherapy control conditions for anxiety disorders. Psychological Medicine 39, 229
    CrossRef

  249. 249

    Suzanne M. Bertisch, Anna R. T. Legedza, Russell S. Phillips, Roger B. Davis, William B. Stason, Rose H. Goldman, Ted J. Kaptchuk. (2009) The impact of psychological factors on placebo responses in a randomized controlled trial comparing sham device to dummy pill. Journal of Evaluation in Clinical Practice 15:10.1111/jep.2009.15.issue-1, 14-19
    CrossRef

  250. 250

    Sae Yong Lee, Patrick McKeon, Jay Hertel. (2009) Does the use of orthoses improve self-reported pain and function measures in patients with plantar fasciitis? A meta-analysis. Physical Therapy in Sport 10, 12-18
    CrossRef

  251. 251

    A R Stark, J E Tyson, P L Hibberd. (2009) Variation among institutional review boards in evaluating the design of a multicenter randomized trial. Journal of Perinatology 30:3, 163
    CrossRef

  252. 252

    Margaret E. Kemeny. (2009) Psychobiological responses to social threat: Evolution of a psychological model in psychoneuroimmunology. Brain, Behavior, and Immunity 23, 1-9
    CrossRef

  253. 253

    Hideto MIWA. (2009) Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 40, 145-150
    CrossRef

  254. 254

    Antonella Pollo, Fabrizio Benedetti. . The placebo response: neurobiological and clinical issues of neurological relevance. 2009:, 283-294.
    CrossRef

  255. 255

    L.Y. Atlas, T.D. Wager. . The Placebo Response. 2009:, 201-216.
    CrossRef

  256. 256

    Peter la Cour. (2008) Rheumatic Disease and Complementary-Alternative Treatments. JCR: Journal of Clinical Rheumatology 14, 332-337
    CrossRef

  257. 257

    James D. Lewis, Shaokun Chuai, Lisa Nessel, Gary R. Lichtenstein, Faten N. Aberra, Jonas H. Ellenberg. (2008) Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis. Inflammatory Bowel Diseases 14, 1660-1666
    CrossRef

  258. 258

    Chung-Yao Chen, Chia-Ling Chen, Steele Chih-Chin Hsu, Shih-Wei Chou, Kun-Chung Wang. (2008) Effect of Magnetic Knee Wrap on Quadriceps Strength in Patients With Symptomatic Knee Osteoarthritis. Archives of Physical Medicine and Rehabilitation 89, 2258-2264
    CrossRef

  259. 259

    Helmut Raab, Karl H. Lindner, Volker Wenzel. (2008) Preventing cardiac arrest during hemorrhagic shock with vasopressin. Critical Care Medicine 36, S474-S480
    CrossRef

  260. 260

    Rohit Loomba, Robert Wesley, Frank Pucino, T. Jake Liang, David E. Kleiner, Joel E. Lavine. (2008) Placebo in Nonalcoholic Steatohepatitis: Insight Into Natural History and Implications for Future Clinical Trials. Clinical Gastroenterology and Hepatology 6, 1243-1248
    CrossRef

  261. 261

    Luana Colloca, Damien Finniss, Fabrizio Benedetti. . Placebo and nocebo. 2008:, 499-513.
    CrossRef

  262. 262

    Anne Holbrook, Charles H. Goldsmith, Mova Leung. . Placebos. 2008.
    CrossRef

  263. 263

    Anne Holbrook, Charles H. Goldsmith, Mova Leung. . Placebos. 2008.
    CrossRef

  264. 264

    M. PASCUA, C. SU, J. D. LEWIS, C. BRENSINGER, G. R. LICHTENSTEIN. (2008) Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics 28:10.1111/apt.2008.28.issue-5, 545-556
    CrossRef

  265. 265

    RM Douglas, H Hemilä, E Chalker, B Treacy. (2008) Cochrane review: Vitamin C for preventing and treating the common cold. Evidence-Based Child Health: A Cochrane Review Journal 3:10.1002/ebch.v3:3, 672-720
    CrossRef

  266. 266

    Michael JL Sullivan, Mary E Lynch, A John Clark, Tsipora Mankovsky, Jana Sawynok. (2008) Catastrophizing and treatment outcome: differential impact on response to placebo and active treatment outcome. Contemporary Hypnosis 25:10.1002/ch.v25:3/4, 129-140
    CrossRef

  267. 267

    Yanlin Wang-Fischer, Lee Koetzner. . Study Design in Animal Models of Stroke. 2008:, 305-313.
    CrossRef

  268. 268

    James Malone-Lee. (2008) A defence of rigorous method in clinical science. Neurourology and Urodynamics 27:10.1002/nau.v27:6, 462-465
    CrossRef

  269. 269

    Carmen Paradis. (2008) Bias in Surgical Research. Annals of Surgery 248, 180-188
    CrossRef

  270. 270

    H. HEMILÄ. (2008) Assessment of the importance of double-blinding should be based on systematic reviews: a rebuttal. Journal of Thrombosis and Haemostasis 6, 1247-1248
    CrossRef

  271. 271

    Ted J. Kaptchuk, John M. Kelley, Aaron Deykin, Peter M. Wayne, Louis C. Lasagna, Ingrid O. Epstein, Irving Kirsch, Michael E. Wechsler. (2008) Do “placebo responders” exist?. Contemporary Clinical Trials 29, 587-595
    CrossRef

  272. 272

    Carolina Kimie Moriyama, Bruna Oneda, Fernanda Rocchi Bernardo, Crivaldo Gomes Cardoso, Claudia L. M. Forjaz, Sandra B. Abrahao, Décio Mion, Ângela M. Fonseca, Tais Tinucci. (2008) A randomized, placebo-controlled trial of the effects of physical exercises and estrogen therapy on health-related quality of life in postmenopausal women. Menopause 15, 613-618
    CrossRef

  273. 273

    E. M. Tsapakis, F. Soldani, L. Tondo, R. J. Baldessarini. (2008) Efficacy of antidepressants in juvenile depression: meta-analysis. The British Journal of Psychiatry 193, 10-17
    CrossRef

  274. 274

    Winfried Rief, Stefan G. Hofmann, Yvonne Nestoriuc. (2008) The Power of Expectation – Understanding the Placebo and Nocebo Phenomenon. Social and Personality Psychology Compass 2:10.1111/spco.2008.2.issue-4, 1624-1637
    CrossRef

  275. 275

    Vanda Faria, Mats Fredrikson, Tomas Furmark. (2008) Imaging the placebo response: A neurofunctional review. European Neuropsychopharmacology 18, 473-485
    CrossRef

  276. 276

    Anneluuk Lindenhovius, Marjolijn Henket, Brendan P. Gilligan, Santiago Lozano-Calderon, Jesse B. Jupiter, David Ring. (2008) Injection of Dexamethasone Versus Placebo for Lateral Elbow Pain: A Prospective, Double-Blind, Randomized Clinical Trial. The Journal of Hand Surgery 33, 909-919
    CrossRef

  277. 277

    Paul Enck, Fabrizio Benedetti, Manfred Schedlowski. (2008) New Insights into the Placebo and Nocebo Responses. Neuron 59, 195-206
    CrossRef

  278. 278

    B. S. Oken. (2008) Placebo effects: clinical aspects and neurobiology. Brain 131, 2812-2823
    CrossRef

  279. 279

    Hannes G Lienhart, Karl H Lindner, Volker Wenzel. (2008) Developing alternative strategies for the treatment of traumatic haemorrhagic shock. Current Opinion in Critical Care 14, 247-253
    CrossRef

  280. 280

    F Schwarz, D Christie. (2008) Use of ‘sham’ radiotherapy in randomized clinical trials. Journal of Medical Imaging and Radiation Oncology 52, 269-277
    CrossRef

  281. 281

    Antonella Pollo, Fabrizio Benedetti. (2008) Placebo Response: Relevance to the Rheumatic Diseases. Rheumatic Disease Clinics of North America 34, 331-349
    CrossRef

  282. 282

    J. Oeltjenbruns, M. Schäfer. (2008) Klinische Bedeutung des Placeboeffektes. Der Anaesthesist 57, 447-463
    CrossRef

  283. 283

    Satoru Shikata, Takeo Nakayama, Hisakazu Yamagishi. (2008) Quality of surgical randomized controlled trials for acute cholecystitis: assessment based on CONSORT and additional check items. Journal of Hepato-Biliary-Pancreatic Surgery 15, 297-303
    CrossRef

  284. 284

    Harri Hemilä, Teija Koivula, Harri Hemilä. . Vitamin C for preventing and treating tetanus. 2008.
    CrossRef

  285. 285

    Christopher G. Goetz, Joanne Wuu, Michael P. McDermott, Charles H. Adler, Stanley Fahn, Curt R. Freed, Robert A. Hauser, Warren C. Olanow, Ira Shoulson, P.K. Tandon, , Sue Leurgans. (2008) Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions. Movement Disorders 23, 690-699
    CrossRef

  286. 286

    MARJEAN TAYLOR KULP, ERIC BORSTING, G LYNN MITCHELL, MITCHELL SCHEIMAN, SUSAN COTTER, JEFFREY COOPER, MICHAEL ROUSE, RICHARD LONDON, JANICE WENSVEEN. (2008) Feasibility of Using Placebo Vision Therapy in a Multicenter Clinical Trial. Optometry and Vision Science 85, 255-261
    CrossRef

  287. 287

    David C. Nieman. (2008) RESPONSE. Medicine & Science in Sports & Exercise 40, 776
    CrossRef

  288. 288

    Ricardo Fernandes, Joaquim J. Ferreira, Cristina Sampaio. (2008) The Placebo Response in Studies of Acute Migraine. The Journal of Pediatrics 152, 527-533.e1
    CrossRef

  289. 289

    Philip D Shenefelt. (2008) Therapeutic management of psychodermatological disorders. Expert Opinion on Pharmacotherapy 9, 973-985
    CrossRef

  290. 290

    Reinhild Klein, Sandra Buck, Karen Claßen, Matthias Rostock, Roman Huber. (2008) Enhanced in vitro activation of immunocompetent cells in healthy individuals being subcutaneously ‘vaccinated’ with placebo (physiological saline). Clinical Immunology 126, 322-331
    CrossRef

  291. 291

    Thomas Ostermann, Gisela Blaser, Mathias Bertram, Andreas Michalsen, Peter F. Matthiessen, Karin Kraft. (2008) Effects of Rhythmic Embrocation Therapy With Solum Oil in Chronic Pain Patients. The Clinical Journal of Pain 24, 237-243
    CrossRef

  292. 292

    Benno Brinkhaus, Daniel Pach, Rainer Lüdtke, Stefan N. Willich. (2008) Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials. Contemporary Clinical Trials 29, 149-156
    CrossRef

  293. 293

    Luana Colloca, Fabrizio Benedetti, Carlo Adolfo Porro. (2008) Experimental designs and brain mapping approaches for studying the placebo analgesic effect. European Journal of Applied Physiology 102, 371-380
    CrossRef

  294. 294

    Steven J. Kamper, Luciana A.C. Machado, Robert D. Herbert, Christopher G. Maher, James H. McAuley. (2008) Trial methodology and patient characteristics did not influence the size of placebo effects on pain. Journal of Clinical Epidemiology 61, 256-260
    CrossRef

  295. 295

    Romain Forestier, Alain Françon. (2008) Crénobalnéothérapie de l’arthrose des membres, revue systématique et analyse méthodologique. Revue du Rhumatisme 75, 214-224
    CrossRef

  296. 296

    Sibylle Klosterhalfen, Paul Enck. (2008) Neurophysiology and psychobiology of the placebo response. Current Opinion in Psychiatry 21, 189-195
    CrossRef

  297. 297

    Romain Forestier, Alain Françon. (2008) Crenobalneotherapy for limb osteoarthritis: Systematic literature review and methodological analysis. Joint Bone Spine 75, 138-148
    CrossRef

  298. 298

    Fabrizio Benedetti. (2008) Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments. Annual Review of Pharmacology and Toxicology 48, 33-60
    CrossRef

  299. 299

    W. Zhang, R.W. Moskowitz, G. Nuki, S. Abramson, R.D. Altman, N. Arden, S. Bierma-Zeinstra, K.D. Brandt, P. Croft, M. Doherty, M. Dougados, M. Hochberg, D.J. Hunter, K. Kwoh, L.S. Lohmander, P. Tugwell. (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 16, 137-162
    CrossRef

  300. 300

    Heather O Dickinson, Fiona R Beyer, Gary A Ford, Donald Nicolson, Fiona Campbell, Julia V Cook, James Mason, Heather O Dickinson. . Relaxation therapies for the management of primary hypertension in adults. 2008.
    CrossRef

  301. 301

    Graeme Hawthorne, Robert Goldney, Anne W. Taylor. (2008) Depression prevalence: is it really increasing?. Australian and New Zealand Journal of Psychiatry 42, 606-616
    CrossRef

  302. 302

    C. Mel Wilcox. (2008) Exploring the use of the sham design for interventional trials: implications for endoscopic research. Gastrointestinal Endoscopy 67, 123-127
    CrossRef

  303. 303

    Jennifer Jo Thompson, Cheryl Ritenbaugh, Mark Nichter. (2008) Reconsidering the Placebo Response from a Broad Anthropological Perspective. Culture, Medicine, and Psychiatry 33:1, 112
    CrossRef

  304. 304

    Michael R. Graham, Julien S. Baker, Peter Evans, Andrew Kicman, David Cowan, David Hullin, Non Thomas, Bruce Davies. (2008) Physical Effects of Short-Term Recombinant Human Growth Hormone Administration in Abstinent Steroid Dependency. Hormone Research 69, 343-354
    CrossRef

  305. 305

    Rémy Boussageon, François Gueyffier, Theodora Bejan-Angoulvant, Géraldine Felden-Dominiak. (2008) Critique du modèle additif de l'essai clinique randomisé. Thérapie 63, 29-35
    CrossRef

  306. 306

    Alireza Ahmadi, David C. Schwebel, Mansour Rezaei. (2008) The Efficacy of Wet-Cupping in the Treatment of Tension and Migraine Headache. The American Journal of Chinese Medicine 36, 37-44
    CrossRef

  307. 307

    Donald D. Price, Damien G. Finniss, Fabrizio Benedetti. (2008) A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought. Annual Review of Psychology 59, 565-590
    CrossRef

  308. 308

    Rachel Sherman, John Hickner. (2008) Academic Physicians Use Placebos in Clinical Practice and Believe in the Mind–Body Connection. Journal of General Internal Medicine 23, 7-10
    CrossRef

  309. 309

    Psychological Modulation of Pain. 2008:, 975-1002.
    CrossRef

  310. 310

    Yair Sharav, Rafael Benoliel. . Complementary and alternative medicine. 2008:, 407-415.
    CrossRef

  311. 311

    Bruce A. Buehler. (2007) Complementary and alternative medicine (CAM) in genetics. American Journal of Medical Genetics Part A 143A:10.1002/ajmg.a.v143a:24, 2889-2892
    CrossRef

  312. 312

    Kenneth F. Schulz. . Double-Dummy. 2007.
    CrossRef

  313. 313

    Reidar Aarskog, Mark I. Johnson, Jan Hendrik Demmink, Anne Lofthus, Vegard Iversen, Rodrigo Lopes-Martins, Jon Joensen, Jan M. Bjordal. (2007) Is mechanical pain threshold after transcutaneous electrical nerve stimulation (TENS) increased locally and unilaterally? A randomized placebo-controlled trial in healthy subjects. Physiotherapy Research International 12:10.1002/pri.v12:4, 251-263
    CrossRef

  314. 314

    Enno Freye, Joseph Victor Levy, Dagmar Braun. (2007) Effervescent Morphine Results in Faster Relief of Breakthrough Pain in Patients Compared to Immediate Release Morphine Sulfate Tablet. Pain Practice 7:10.1111/ppr.2007.7.issue-4, 324-331
    CrossRef

  315. 315

    Jason G. Craggs, Donald D. Price, G. Nicholas Verne, William M. Perlstein, Michael M. Robinson. (2007) Functional brain interactions that serve cognitive–affective processing during pain and placebo analgesia. NeuroImage 38, 720-729
    CrossRef

  316. 316

    David M. Marsh, Teresa J. Hanlon. (2007) Seeing What We Want to See: Confirmation Bias in Animal Behavior Research. Ethology 113:10.1111/eth.2007.113.issue-11, 1089-1098
    CrossRef

  317. 317

    R. Jungbecker, M. Zenz. (2007) BGH-Urteil zum Racz-Katheter. Der Schmerz 21, 553-556
    CrossRef

  318. 318

    Bruce Barrett, Dave Rakel, Betty Chewning, Lucille Marchand, David Rabago, Roger Brown, Jo Scheder, Raandi Schmidt, James E. Gern, Kerry Bone, Gay Thomas, Shari Barlow, James Bobula. (2007) Rationale and Methods for a Trial Assessing Placebo, Echinacea, and Doctor-Patient Interaction in the Common Cold. EXPLORE: The Journal of Science and Healing 3, 561-572
    CrossRef

  319. 319

    Roman Huber, Amelie v. Ditfurth, Frank Amann, Corina Güthlin, Matthias Rostock, Rainer Trittler, Klaus Kümmerer, Irmgard Merfort. (2007) Tormentil for Active Ulcerative Colitis. Journal of Clinical Gastroenterology 41, 834-838
    CrossRef

  320. 320

    John L. Sievenpiper, Adish Ezatagha, Anamaria Dascalu, Vladimir Vuksan. (2007) When a placebo is not a ?placebo?: a placebo effect on postprandial glycaemia. British Journal of Clinical Pharmacology 64:10.1111/bcp.2007.64.issue-4, 546-549
    CrossRef

  321. 321

    Jan Van Zundert. (2007) Clinical Research in Interventional Pain Management Techniques: The Clinician's Point of View. Pain Practice 7:10.1111/ppr.2007.7.issue-3, 221-229
    CrossRef

  322. 322

    Patricia A. Roche. (2007) Pain and placebo analgesia: two sides of the same coin. Physical Therapy Reviews 12, 189-198
    CrossRef

  323. 323

    Laura McRee, Alice Pasvogel, Alton V. Hallum, Steve E. Behr, Francisco A.R. Garcia, Robert G. Loeb. (2007) Effects of Preoperative Massage on Intra- and Postoperative Outcomes. Journal of Gynecologic Surgery 23, 97-104
    CrossRef

  324. 324

    Celal B. Erdogmus, Karl-Ludwig Resch, Ronald Sabitzer, Horst M??ller, Martin Nuhr, Andreas Sch??ggl, Martin Posch, Wolf Osterode, Karl Ungersb??ck, Gerold R. Ebenbichler. (2007) Physiotherapy-Based Rehabilitation Following Disc Herniation Operation. Spine 32, 2041-2049
    CrossRef

  325. 325

    E. Randy Eichner. (2007) Sports medicine pearls and pitfalls: Pearls on the power of placebo. Current Sports Medicine Reports 6, 208-209
    CrossRef

  326. 326

    s. d. dorn, t. j. kaptchuk, j. b. park, l. t. nguyen, k. canenguez, b. h. nam, k. b. woods, l. a. conboy, w. B. stason, a. j. lembo. (2007) A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterology & Motility 19:10.1111/nmo.2007.19.issue-8, 630-637
    CrossRef

  327. 327

    E. Randy Eichner. (2007) Sports Medicine Pearls and Pitfalls. Current Sports Medicine Reports 6, 208-209
    CrossRef

  328. 328

    Harri Hemilä, Elizabeth Chalker, Bob Douglas, Harri Hemilä. . Vitamin C for preventing and treating the common cold. 2007.
    CrossRef

  329. 329

    H-C Diener, G Bussone, JC Van Oene, M Lahaye, S Schwalen, PJ Goadsby, . (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:10.1111/cha.2007.27.issue-7, 814-823
    CrossRef

  330. 330

    David J. Scott, Christian S. Stohler, Christine M. Egnatuk, Heng Wang, Robert A. Koeppe, Jon-Kar Zubieta. (2007) Individual Differences in Reward Responding Explain Placebo-Induced Expectations and Effects. Neuron 55, 325-336
    CrossRef

  331. 331

    Haim Shmuely, Jacob Yahav, Zmira Samra, Gabriel Chodick, Rivka Koren, Yaron Niv, Itzhak Ofek. (2007) Effect of cranberry juice on eradication ofHelicobacter pyloriin patients treated with antibiotics and a proton pump inhibitor. Molecular Nutrition & Food Research 51:10.1002/mnfr.v51:6, 746-751
    CrossRef

  332. 332

    Stephen Polgar, Joanna Ng. (2007) A critical analysis of evidence for using sham surgery in Parkinson's disease: implications for public health. Australian and New Zealand Journal of Public Health 31:10.1111/azph.2007.31.issue-3, 270-274
    CrossRef

  333. 333

    Margaret E. Kemeny, Lanny J. Rosenwasser, Reynold A. Panettieri, Robert M. Rose, Steve M. Berg-Smith, Joel N. Kline. (2007) Placebo response in asthma: A robust and objective phenomenon. Journal of Allergy and Clinical Immunology 119, 1375-1381
    CrossRef

  334. 334

    Andrew L. Geers, Kristin Kosbab, Suzanne G. Helfer, Paul E. Weiland, Justin A. Wellman. (2007) Further evidence for individual differences in placebo responding: An interactionist perspective. Journal of Psychosomatic Research 62, 563-570
    CrossRef

  335. 335

    R. Forestier, A. Françon, F. Saint-Arromand, C. Bertolino, A. Guillemot, B. Graber-Duvernay, M. Slikh, B. Duplan. (2007) Y a-t-il un effet des soins thermaux et des champs électromagnétiques pulsés sur la cervicalgie chronique? Essai clinique randomisé Première partie: étude clinique. Annales de Réadaptation et de Médecine Physique 50, 140-147
    CrossRef

  336. 336

    Bruce E. Wampold, Zac E. Imel, Takuya Minami. (2007) The placebo effect: “Relatively large” and “robust” enough to survive another assault. Journal of Clinical Psychology 63:10.1002/jclp.v63:4, 401-403
    CrossRef

  337. 337

    Asbjørn Hróbjartsson, Peter C. Gøtzsche. (2007) Powerful spin in the conclusion of wampold et al.'s re-analysis of placebo versus no-treatment trials despite similar results as in original review. Journal of Clinical Psychology 63:10.1002/jclp.v63:4, 373-377
    CrossRef

  338. 338

    Bruce E. Wampold, Zac E. Imel, Takuya Minami. (2007) The story of placebo effects in medicine: Evidence in context. Journal of Clinical Psychology 63:10.1002/jclp.v63:4, 379-390
    CrossRef

  339. 339

    Beverly Thorn. (2007) Commentaries on the placebo concept in psychotherapy. Journal of Clinical Psychology 63:10.1002/jclp.v63:4, 371-372
    CrossRef

  340. 340

    Asbjørn Hróbjartsson, Peter C. Gøtzsche. (2007) Wampold et al.'s reiterate spin in the conclusion of a re-analysis of placebo versus no-treatment trials despite similar results as in original review. Journal of Clinical Psychology 63:10.1002/jclp.v63:4, 405-408
    CrossRef

  341. 341

    John Hunsley, Robin Westmacott. (2007) Interpreting the magnitude of the placebo effect: Mountain or molehill?. Journal of Clinical Psychology 63:10.1002/jclp.v63:4, 391-399
    CrossRef

  342. 342

    Klaus Linde, Claudia M. Witt, Andrea Streng, Wolfgang Weidenhammer, Stefan Wagenpfeil, Benno Brinkhaus, Stefan N. Willich, Dieter Melchart. (2007) The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128, 264-271
    CrossRef

  343. 343

    Stephen Senn. (2007) Statistics in the pharmaceutical industry (3rd edn). C. Ralph Buncher and Jia-Yeong Tsay (eds), Chapman & Hall/CRC, New York, 2006. No. of pages: xxiii+473. Price: $119.95. ISBN: 0-8247-5469-7. Statistics in Medicine 26:10.1002/sim.v26:7, 1651-1652
    CrossRef

  344. 344

    John C. Licciardone. (2007) Responding to the challenge of clinically relevant osteopathic research: Efficacy and beyond. International Journal of Osteopathic Medicine 10, 3-7
    CrossRef

  345. 345

    E. C.-H. Lim, R. C. S. Seet. (2007) Attitudes of medical students to placebo therapy. Internal Medicine Journal 37:10.1111/imj.2007.37.issue-3, 156-160
    CrossRef

  346. 346

    Edvin B. Koshi, Christine Ann Short. (2007) Placebo Theory and Its Implications for Research and Clinical Practice: A Review of the Recent Literature. Pain Practice 7:10.1111/ppr.2007.7.issue-1, 4-20
    CrossRef

  347. 347

    Simon Wessely. (2007) A Defence of the Randomized Controlled Trial in Mental Health. BioSocieties 2, 115-127
    CrossRef

  348. 348

    LYNDA BÉLANGER, ANNIE VALLIÈRES, HANS IVERS, VINCENT MOREAU, GILLES LAVIGNE, CHARLES M. MORIN. (2007) Meta-analysis of sleep changes in control groups of insomnia treatment trials. Journal of Sleep Research 16:10.1111/jsr.2007.16.issue-1, 77-84
    CrossRef

  349. 349

    Aaron K. Vallance. (2007) A systematic review comparing the functional neuroanatomy of patients with depression who respond to placebo to those who recover spontaneously: Is there a biological basis for the placebo effect in depression?. Journal of Affective Disorders 98, 177-185
    CrossRef

  350. 350

    An-Shine Chao, Angel Chao, Tzu-Hao Wang, Yu-Cheng Chang, Hsiu-Huei Peng, Shuenn-Dyh Chang, Anne Chao, Chee-Jen Chang, Chyong-Huey Lai, Alice M.K. Wong. (2007) Pain relief by applying transcutaneous electrical nerve stimulation (TENS) on acupuncture points during the first stage of labor: A randomized double-blind placebo-controlled trial. Pain 127, 214-220
    CrossRef

  351. 351

    Teresa Forcades, Josefina Caminal, Núria Rodríguez, Teresa Gutiérrez. (2007) Efecto placebo frente a efecto terapéutico en la práctica clínica y medicinas complementarias y alternativas. Atención Primaria 39, 99-102
    CrossRef

  352. 352

    Shuu-Jiun Wang, Jong-Ling Fuh, Zin-An Wu. (2007) Intranasal Sumatriptan Study with High Placebo Response in Taiwanese Patients with Migraine. Journal of the Chinese Medical Association 70, 39-46
    CrossRef

  353. 353

    Harri Hemilä, Pekka Louhiala, Harri Hemilä. . Vitamin C for preventing and treating pneumonia. 2007.
    CrossRef

  354. 354

    Howard L. Fields, Donald D. Price. . Analgesia mediante placebo. 2007:, 369-376.
    CrossRef

  355. 355

    E. Gatbois, D. Annequin. (2007) Tratamiento del dolor en los niños de 1 mes a 15 años. EMC - Tratado de Medicina 11, 1-13
    CrossRef

  356. 356

    H Hemilä, TT Koivula, Harri Hemilä. . Cochrane Database of Systematic Reviews Protocols. 2007.
    CrossRef

  357. 357

    E. Gatbois, D. Annequin. (2007) Prise en charge de la douleur chez l'enfant de 1 mois à 15 ans. EMC - Traité de médecine AKOS 2, 1-13
    CrossRef

  358. 358

    Frank Zimmermann-Viehoff, Karin Meissner. (2007) Homeopathy and Placebo – Synonym, Similar or Different?. Forschende Komplementärmedizin / Research in Complementary Medicine 14, 247-248
    CrossRef

  359. 359

    Heinz-Dieter Basler, Helmut Bertalanffy, Sabine Quint, Axel Wilke, Udo Wolf. (2007) TTM-based counselling in physiotherapy does not contribute to an increase of adherence to activity recommendations in older adults with chronic low back pain – A randomised controlled trial. European Journal of Pain 11, 31-37
    CrossRef

  360. 360

    HP Rang, MM Dale, JM Ritter, RJ Flower. . Method and measurement in pharmacology. 2007:, 87-97.
    CrossRef

  361. 361

    Michael Frass. . Aspekte einer begleitenden homöopathischen Behandlung in der Intensivmedizin. 2007:, 61-70.
    CrossRef

  362. 362

    J��rgen Windeler. (2007) Placebo-Effekte. Zeitschrift f��r ��rztliche Fortbildung und Qualit��t im Gesundheitswesen - German Journal for Quality in Health Care 101:5, 307.e1
    CrossRef

  363. 363

    Marcus Zulian Teixeira. . Übersicht zur Forschung in der Homöopathie. 2007:, 25-34.
    CrossRef

  364. 364

    Donald D. Price, Jason Craggs, G. Nicholas Verne, William M. Perlstein, Michael E. Robinson. (2007) Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127, 63-72
    CrossRef

  365. 365

    Jan Van Zundert, Jacob Patijn, Alfons Kessels, Inge Lamé, Hans van Suijlekom, Maarten van Kleef. (2007) Pulsed radiofrequency adjacent to the cervical dorsal root ganglion in chronic cervical radicular pain: A double blind sham controlled randomized clinical trial. Pain 127, 173-182
    CrossRef

  366. 366

    Brian Olshansky. (2007) Placebo and Nocebo in Cardiovascular Health. Journal of the American College of Cardiology 49, 415-421
    CrossRef

  367. 367

    E. Ernst. (2007) Placebo, deceit and complementary/alternative medicine. Climacteric 10, 85-87
    CrossRef

  368. 368

    Birgit Rösblad, Gerd Andersson, Kurt Pettersson. (2007) Effects of botulinum toxin type A and a programme of functional activity to improve manual ability in children and adolescents with cerebral palsy. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 41, 250-258
    CrossRef

  369. 369

    Daniel E. Moerman. (2006) The Meaning Response: Thinking about Placebos. Pain Practice 6:10.1111/ppr.2006.6.issue-4, 233-236
    CrossRef

  370. 370

    Rainer Schneider, Mauritz Grüner, Alexandra Heiland, Martina Keller, Zuzana Kujanová, Martin Peper, Maximilian Riegl, Stefan Schmidt, Petra Volz, Harald Walach. (2006) Effects of expectation and caffeine on arousal, well-being, and reaction time. International Journal of Behavioral Medicine 13, 330-339
    CrossRef

  371. 371

    Donald D. Price, Roger B. Fillingim, Michael E. Robinson. (2006) Placebo analgesia: Friend or foe?. Current Rheumatology Reports 8, 418-424
    CrossRef

  372. 372

    Charles N. Bernstein. (2006) The Placebo Effect for Gastroenterology: Tool or Torment. Clinical Gastroenterology and Hepatology 4, 1302-1308
    CrossRef

  373. 373

    Bradley Chipps, Roland Buhl, Kai-Michael Beeh, Howard Fox, Karen Thomas, Colin Reisner. (2006) Improvement in quality of life with omalizumab in patients with severe allergic asthma. Current Medical Research and Opinion 22, 2201-2208
    CrossRef

  374. 374

    Paul S. Heckerling. (2006) Placebo surgery research: A blinding imperative. Journal of Clinical Epidemiology 59, 876-880
    CrossRef

  375. 375

    Jules H. Schagen van Leeuwen, Ramiro Castro, Michael Busse, Bart L.H. Bemelmans. (2006) The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms. European Urology 50, 440-453
    CrossRef

  376. 376

    Gustavo Pacheco-López, Harald Engler, Maj-Britt Niemi, Manfred Schedlowski. (2006) Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain, Behavior, and Immunity 20, 430-446
    CrossRef

  377. 377

    Luana Colloca, Fabrizio Benedetti. (2006) How prior experience shapes placebo analgesia. Pain 124, 126-133
    CrossRef

  378. 378

    K. Linde. (2006) Der spezifische Placeboeffekt. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 49, 729-735
    CrossRef

  379. 379

    Peter Jüni, Stephan Reichenbach, Paul Dieppe. (2006) Osteoarthritis: rational approach to treating the individual. Best Practice & Research Clinical Rheumatology 20, 721-740
    CrossRef

  380. 380

    Robert L. Tiel, David G. Kline. (2006) Piriformis Syndrome. Journal of Neurosurgery: Spine 5, 102-104
    CrossRef

  381. 381

    Gerhard Schüßler. (2006) Blick in internationale Zeitschriften. Zeitschrift für Psychosomatische Medizin und Psychotherapie 52, 81-85
    CrossRef

  382. 382

    D D'Amico, A Solari, S Usai, P Santoro, P Bernardoni, F Frediani, R De Marco, N Massetto, G Bussone, . (2006) Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 26:10.1111/cha.2006.26.issue-6, 691-696
    CrossRef

  383. 383

    H Drutz. (2006) Duloxetine in women awaiting surgery. BJOG: An International Journal of Obstetrics & Gynaecology 113, 17-21
    CrossRef

  384. 384

    Carmen WH Chan, David R Thompson. (2006) The use of placebo in clinical nursing research. Journal of Clinical Nursing 15:10.1111/jcn.2006.15.issue-5, 521-524
    CrossRef

  385. 385

    Michael A. Posternak, David A. Solomon, Andrew C. Leon, Timothy I. Mueller, M Tracie Shea, Jean Endicott, Martin B. Keller. (2006) The Naturalistic Course of Unipolar Major Depression in the Absence of Somatic Therapy. The Journal of Nervous and Mental Disease 194, 324-329
    CrossRef

  386. 386

    Max E. Levine, Robert M. Stern, Kenneth L. Koch. (2006) The Effects of Manipulating Expectations Through Placebo and Nocebo Administration on Gastric Tachyarrhythmia and Motion-Induced Nausea. Psychosomatic Medicine 68, 478-486
    CrossRef

  387. 387

    Miriam V. Mills. (2006) Consider osteopathic manipulation in next positional plagiocephaly research. The Journal of Pediatrics 148, 706-707
    CrossRef

  388. 388

    Tor D. Wager, Dagfinn Matre, Kenneth L. Casey. (2006) Placebo effects in laser-evoked pain potentials. Brain, Behavior, and Immunity 20, 219-230
    CrossRef

  389. 389

    Rémy Boussageon, François Gueyffier, Alain Moreau, Vincent Boussageon. (2006) La difficile mesure de l'effet placebo. Thérapie 61, 185-190
    CrossRef

  390. 390

    Harri Hemilä. (2006) Analysis of clinical data with breached blindness by Shein-Chung Chow and Jun Shao,Statistics in Medicine 2004;23:1185–1193. Statistics in Medicine 25:10.1002/sim.v25:8, 1434-1437
    CrossRef

  391. 391

    Chinyu Su. (2006) Outcomes of placebo therapy in inflammatory bowel disease. Inflammatory Bowel Diseases 12, 328-333
    CrossRef

  392. 392

    Franklin G. Miller, Donald L. Rosenstein. (2006) The nature and power of the placebo effect. Journal of Clinical Epidemiology 59, 331-335
    CrossRef

  393. 393

    Asbjørn Hróbjartsson, Peter C. Gøtzsche. (2006) Follow-up Commentary. Journal of Clinical Epidemiology 59, 340-341
    CrossRef

  394. 394

    Stephen Birch. (2006) A Review and Analysis of Placebo Treatments, Placebo Effects, and Placebo Controls in Trials of Medical Procedures When Sham Is Not Inert. The Journal of Alternative and Complementary Medicine 12, 303-310
    CrossRef

  395. 395

    Asbjørn Hróbjartsson, Peter C. Gøtzsche. (2006) Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies. Journal of Clinical Epidemiology 59, 336-338
    CrossRef

  396. 396

    Franklin G. Miller, Donald L. Rosenstein. (2006) Response to Commentary. Journal of Clinical Epidemiology 59, 339
    CrossRef

  397. 397

    Mark A. Young, Jill L. Cook, Kate E. Webster. (2006) The effect of topical wheatgrass cream on chronic plantar fasciitis: A randomized, double-blind, placebo-controlled trial. Complementary Therapies in Medicine 14, 3-9
    CrossRef

  398. 398

    Ana Macedo, Magí Farré, Josep-E. Baños. (2006) A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials. European Journal of Clinical Pharmacology 62, 161-172
    CrossRef

  399. 399

    Jacek Spławiński, Jerzy Kuźniar, Krzysztof Filipiak, Waldemar Zieliński. (2006) Evaluation of drug toxicity in clinical trials. Science and Engineering Ethics 12, 139-145
    CrossRef

  400. 400

    M. Eikermann, T. H.C. Kruger, B. Schiffer, M. Beiderlinden, M. Forsting, M. Schedlowski. (2006) Importance of non-pharmacological mechanism of analgesia with spinal puncture. Acta Anaesthesiologica Scandinavica 50:10.1111/aas.2006.50.issue-3, 389-389
    CrossRef

  401. 401

    Jon-Kar Zubieta, Wai-Ying Yau, David J. Scott, Christian S. Stohler. (2006) Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect. Brain, Behavior, and Immunity 20, 15-26
    CrossRef

  402. 402

    Howard L. Fields, Donald D. Price. . Placebo analgesia. 2006:, 361-367.
    CrossRef

  403. 403

    Bruno Matard, Pascal Reygagne. (2006) Traitements antichutes. EMC - Cosmétologie et dermatologie esthétique 1, 1-7
    CrossRef

  404. 404

    R. Ben-Youssef, P.W. Baron, E. Franco, M.H. Walter, T. Lewis, O. Ojogho. (2006) Intrapyloric Injection of Botulinum Toxin A for the Treatment of Persistent Gastroparesis Following Successful Pancreas Transplantation. American Journal of Transplantation 6:10.1111/ajt.2006.6.issue-1, 214-218
    CrossRef

  405. 405

    Felipe Fregni, Paulo S. Boggio, Felix Bermpohl, Fernanda Maia, Sergio P. Rigonatti, Egberto R. Barbosa, Alvaro Pascual-Leone. (2006) Immediate Placebo Effect in Parkinson&rsquo;s Disease &ndash; Is the Subjective Relief Accompanied by Objective Improvement?. European Neurology 56, 222-229
    CrossRef

  406. 406

    Baba Shiv, Antoine Bechara, Irwin Levin, Joseph W. Alba, James R. Bettman, Laurette Dube, Alice Isen, Barbara Mellers, Ale Smidts, Susan J. Grant, A. Peter Mcgraw. (2005) Decision Neuroscience. Marketing Letters 16, 375-386
    CrossRef

  407. 407

    E. C-H. Lim, E. P. V. Wilder-Smith, B. K. C. Ong, R. C. S. Seet. (2005) Is there a place for placebos in clinical practice?. Internal Medicine Journal 35:10.1111/imj.2005.35.issue-12, 734-735
    CrossRef

  408. 408

    David Borsook, Lino Becerra. (2005) Placebo: From Pain and Analgesia to Preferences and Products. Journal of Marketing Research 42, 394-398
    CrossRef

  409. 409

    H. Helmchen. (2005) Ethische Implikationen plazebokontrollierter Prüfungen von Psychopharmaka. Der Nervenarzt 76, 1319-1329
    CrossRef

  410. 410

    P. J. DEVEREAUX, M. BHANDARI, V. M. MONTORI, B. J. MANNS, W. A. GHALI, G. H. GUYATT. (2005) Double blind, you are the weakest link - goodbye!. Equine Veterinary Journal 37, 557-558
    CrossRef

  411. 411

    Martin B. Leon, Ran Kornowski, William E. Downey, Giora Weisz, Donald S. Baim, Robert O. Bonow, Robert C. Hendel, David J. Cohen, Ernest Gervino, Roger Laham, Nicholas J. Lembo, Jeffrey W. Moses, Richard E. Kuntz. (2005) A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease. Journal of the American College of Cardiology 46, 1812-1819
    CrossRef

  412. 412

    Franklin G. Miller. (2005) Ethical Issues in Surgical Research. Thoracic Surgery Clinics 15, 543-554
    CrossRef

  413. 413

    J.-J. Aulas. (2005) Placebo et effet placebo. Annales Pharmaceutiques Françaises 63, 401-415
    CrossRef

  414. 414

    H Hemilä, P Louhiala, Harri Hemilä. . Vitamin C for preventing and treating pneumonia. 2005.
    CrossRef

  415. 415

    Patrick Onghena. . Placebo Effect. 2005.
    CrossRef

  416. 416

    Fabiana Fratello, Giuseppe Curcio, Michele Ferrara, Cristina Marzano, Alessandro Couyoumdjian, Giovanna Petrillo, Mario Bertini, Luigi Gennaro. (2005) Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures. Psychopharmacology 181, 761-770
    CrossRef

  417. 417

    Helmut Kiene, Gunver S. Kienle, Tido von Schön-Angerer. (2005) Failure to Exclude False Negative Bias: A Fundamental Flaw in the Trial of Shang et al.. The Journal of Alternative and Complementary Medicine 11, 783-783
    CrossRef

  418. 418

    George T. Lewith, Harald Walach, Wayne B. Jonas. (2005) Horton Deplores Breach; As Do We His. The Journal of Alternative and Complementary Medicine 11, 779-779
    CrossRef

  419. 419

    David Reilly. (2005) Sir: Is That Bias?. The Journal of Alternative and Complementary Medicine 11, 785-785
    CrossRef

  420. 420

    Trevor Thompson, Marjorie Weiss. (2005) Understanding Placebo Effects in Homeopathic Clinical Trials. The Journal of Alternative and Complementary Medicine 11, 784-784
    CrossRef

  421. 421

    Erik W. Baars, Anja De Bruin. (2005) The Effect of Gencydo ® Injections on Hayfever Symptoms: A Therapeutic Causality Report. The Journal of Alternative and Complementary Medicine 11, 863-869
    CrossRef

  422. 422

    Stephen Polgar, Joanna Ng. (2005) Ethics, methodology and the use of placebo controls in surgical trials. Brain Research Bulletin 67, 290-297
    CrossRef

  423. 423

    David Peters. (2005) Shang et al. Carelessness, Collusion, or Conspiracy?. The Journal of Alternative and Complementary Medicine 11, 779-780
    CrossRef

  424. 424

    Michael Frass, E. Schuster, Ilse Muchitsch, Jeff Duncan, Walter Gei, Gloria Kozel, Christa Kastinger-Mayr, Anton E. Felleitner, Christian Reiter, Christian Endler, Menachem Oberbaum. (2005) Bias in the Trial and Reporting of Trials of Homeopathy: A Fundamental Breakdown in Peer Review and Standards?. The Journal of Alternative and Complementary Medicine 11, 780-782
    CrossRef

  425. 425

    Philip D. Shenefelt. (2005) Complementary Psychocutaneous Therapies in Dermatology. Dermatologic Clinics 23, 723-734
    CrossRef

  426. 426

    Lars Björkman, Jan Weiner, Nils Roar Gjerdet. (2005) Improvement of health after replacement of amalgam fillings?. Journal of Psychosomatic Research 59, 189-190
    CrossRef

  427. 427

    R. B. Fillingim, D. D. Price. (2005) What Is Controlled for in Placebo-Controlled Trials?. Mayo Clinic Proceedings 80, 1119-1121
    CrossRef

  428. 428

    (2005) Homoeopathy for sepsis?. Focus on Alternative and Complementary Therapies 10, 196-197
    CrossRef

  429. 429

    Per Nerdum. (2005) Response to “Improvement of health after replacement of amalgam fillings” by Björkman et al.. Journal of Psychosomatic Research 59, 191-192
    CrossRef

  430. 430

    Colin Cheyne. (2005) Exploiting Placebo Effects for Therapeutic Benefit. Health Care Analysis 13, 177-188
    CrossRef

  431. 431

    H. H. Harri Hemila. (2005) Echinacea, Vitamin C, the Common Cold, and Blinding. Clinical Infectious Diseases 41, 762-763
    CrossRef

  432. 432

    Anita H. Clayton, Sara G. West, Elizabeth McGarvey, Catherine Leslie, Adrienne Keller. (2005) Biochemical Evidence of the Placebo Effect During the Treatment of Menstrual Migraines. Journal of Clinical Psychopharmacology 25, 400-401
    CrossRef

  433. 433

    Anne Holbrook, Charles H. Goldsmith, Mova Leung. . Placebos. 2005.
    CrossRef

  434. 434

    James D. Herbert, Brandon A. Gaudiano. (2005) Moving from empirically supported treatment lists to practice guidelines in psychotherapy: The role of the placebo concept. Journal of Clinical Psychology 61:10.1002/jclp.v61:7, 893-908
    CrossRef

  435. 435

    James D. Herbert, Brandon A. Gaudiano. (2005) Introduction to the special issue on the placebo concept in psychotherapy. Journal of Clinical Psychology 61:10.1002/jclp.v61:7, 787-790
    CrossRef

  436. 436

    Roy A. E. Bakay. (2005) Neural transplantation. Journal of Neurosurgery 103, 6-8
    CrossRef

  437. 437

    Luana Colloca, Fabrizio Benedetti. (2005) Science and society: Placebos and painkillers: is mind as real as matter?. Nature Reviews Neuroscience 6, 545-552
    CrossRef

  438. 438

    Irving Kirsch. (2005) Placebo psychotherapy: Synonym or oxymoron?. Journal of Clinical Psychology 61:10.1002/jclp.v61:7, 791-803
    CrossRef

  439. 439

    Bruce E. Wampold, Takuya Minami, Sandra Callen Tierney, Thomas W. Baskin, Kuldhir S. Bhati. (2005) The placebo is powerful: Estimating placebo effects in medicine and psychotherapy from randomized clinical trials. Journal of Clinical Psychology 61:10.1002/jclp.v61:7, 835-854
    CrossRef

  440. 440

    Bradly P. Jacobs, Stephen Bent, Jeffrey A. Tice, Terri Blackwell, Steven R. Cummings. (2005) An Internet-Based Randomized, Placebo-Controlled Trial of Kava and Valerian for Anxiety and Insomnia. Medicine 84, 197-207
    CrossRef

  441. 441

    T. D. Borkovec, Nicholas J. Sibrava. (2005) Problems with the use of placebo conditions in psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. Journal of Clinical Psychology 61:10.1002/jclp.v61:7, 805-818
    CrossRef

  442. 442

    Paul Knipschild, Arnoud Arntz. (2005) Pain patients in a randomized trial did not show a significant effect of a positive consultation. Journal of Clinical Epidemiology 58, 708-713
    CrossRef

  443. 443

    John H.K. Vogel, Steven F. Bolling, Rebecca B. Costello, Erminia M. Guarneri, Mitchell W. Krucoff, John C. Longhurst, Brian Olshansky, Kenneth R. Pelletier, Cynthia M. Tracy, Robert A. Vogel, Robert A. Vogel, Jonathan Abrams, Jeffrey L. Anderson, Eric R. Bates, Bruce R. Brodie, Cindy L. Grines, Peter G. Danias, Gabriel Gregoratos, Mark A. Hlatky, Judith S. Hochman, Sanjiv Kaul, Robert C. Lichtenberg, Jonathan R. Lindner, Robert A. O’Rourke, Gerald M. Pohost, Richard S. Schofield, Samuel J. Shubrooks, Cynthia M. Tracy, William L. Winters. (2005) Integrating Complementary Medicine Into Cardiovascular Medicine. Journal of the American College of Cardiology 46, 184-221
    CrossRef

  444. 444

    JONAS NILSSON. (2005) A Bootstrap Theory of Rationality. Theoria 71, 182-199
    CrossRef

  445. 445

    R. Forestier, A. Françon, B. Graber-Duvernay. (2005) Les paramètres de validité d'un essai thérapeutique et leur influence sur l'élaboration d'une médecine fondée sur les preuves : revue de la littérature. Annales de Réadaptation et de Médecine Physique 48, 250-258
    CrossRef

  446. 446

    p. enck, s. klosterhalfen. (2005) The placebo response in functional bowel disorders: perspectives and putative mechanisms.. Neurogastroenterology and Motility 17:10.1111/nmo.2005.17.issue-3, 325-331
    CrossRef

  447. 447

    s. m. patel, w. b. stason, a. legedza, s. m. ock, t. j. kaptchuk, l. conboy, k. canenguez, j. k. park, e. kelly, e. jacobson, c. e. kerr, a. j. lembo. (2005) The placebo effect in irritable bowel syndrome trials: a meta-analysis1. Neurogastroenterology and Motility 17:10.1111/nmo.2005.17.issue-3, 332-340
    CrossRef

  448. 448

    A Kirkley, R G Marx, S Griffin, W R Dunn. (2005) Clinical Trials in Orthopedic Surgery. Sports Medicine and Arthroscopy Review 13, 61-68
    CrossRef

  449. 449

    E Paulsen, L Korsholm, F Brandrup. (2005) A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. Journal of the European Academy of Dermatology and Venereology 19:10.1111/jdv.2005.19.issue-3, 326-331
    CrossRef

  450. 450

    Sarah J. L. Edward, Andrew J. Stevens, David A. Braunholtz, Richard J. Lilford, Teresa Swift. (2005) The Ethics of Placebo-controlled Trials: A Comparison of Inert and Active Placebo Controls. World Journal of Surgery 29, 610-614
    CrossRef

  451. 451

    Shihong Zhang, Ming Liu, Kjell Asplund, Lin Li, Ming Liu. . Acupuncture for acute stroke. 2005.
    CrossRef

  452. 452

    Patrick Onghena. . Placebo Effect. 2005.
    CrossRef

  453. 453

    K. Meissner. (2005) Preferring patient-reported to observer-reported outcomes substantially influences the results of the updated systematic review on placebos by Hróbjartsson and Gøtzsche. Journal of Internal Medicine 257:10.1111/jim.2005.257.issue-4, 394-394
    CrossRef

  454. 454

    Graeme Hawthorne, Richard Osborne. (2005) Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Australian and New Zealand Journal of Public Health 29:10.1111/azph.2005.29.issue-2, 136-142
    CrossRef

  455. 455

    Adrian Sandler. (2005) Placebo effects in developmental disabilities: Implications for research and practice. Mental Retardation and Developmental Disabilities Research Reviews 11:10.1002/mrdd.v11:2, 164-170
    CrossRef

  456. 456

    Leonard S. Milling, Irving Kirsch, George J. Allen, Erin L. Reutenauer. (2005) The effects of hypnotic and nonhypnotic imaginative suggestion on pain. Annals of Behavioral Medicine 29, 116-127
    CrossRef

  457. 457

    M.G. Spigt, P.G. Knipschild, C.P. van Schayck, J.A. Knottnerus. (2005) The validity and ethics of giving placebo in a randomized nonpharmacologic trial was evaluated. Journal of Clinical Epidemiology 58, 350-356
    CrossRef

  458. 458

    Fabio Parazzini, Enrico Colli, Liliane Chatenoud, Matteo Malvezzi, Lorenza Olivieri, Francesco Montorsi, Carlo La Vecchia. (2005) Clinical trials in urology: how many patients are required to achieve statistically significant results?. BJU International 95:10.1111/bju.2005.95.issue-5, 717-722
    CrossRef

  459. 459

    DAVID RESNIK, DARRYL ZELDIN, RICHARD SHARP. (2005) Research on Environmental Health Interventions: Ethical Problems and Solutions. Accountability in Research: Policies and Quality Assurance 12, 69-101
    CrossRef

  460. 460

    Theodore Pincus, Ingrid Amara, Gary G. Koch. (2005) Continuous indices of core data set measures in rheumatoid arthritis clinical trials: Lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis & Rheumatism 52:10.1002/art.v52:4, 1031-1036
    CrossRef

  461. 461

    Donald D. Price, S. Karen Chung, Michael E. Robinson. (2005) Conditioning, expectation, and desire for relief in placebo analgesia. Seminars in Pain Medicine 3, 15-21
    CrossRef

  462. 462

    Daniel E. Moerman, Anne Harrington. (2005) Making space for the placebo effect in pain medicine. Seminars in Pain Medicine 3, 2-6
    CrossRef

  463. 463

    Ted J. Kaptchuk, Franklin G. Miller. (2005) Viewpoint:. Academic Medicine 80, 286-290
    CrossRef

  464. 464

    Hyong Jin Cho, Matthew Hotopf, Simon Wessely. (2005) The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis. Psychosomatic Medicine 67, 301-313
    CrossRef

  465. 465

    Roger Robert, Jean-Jacques Labat, Maurice Bensignor, Pascal Glemain, Cédric Deschamps, Sylvie Raoul, Olivier Hamel. (2005) Decompression and Transposition of the Pudendal Nerve in Pudendal Neuralgia: A Randomized Controlled Trial and Long-Term Evaluation. European Urology 47, 403-408
    CrossRef

  466. 466

    C. Guy-Coichard, F. Boureau. (2005) Comprendre l’effet placebo pour mieux traiter la douleur. La Revue de Médecine Interne 26, 226-232
    CrossRef

  467. 467

    Veronica Morton, David J. Torgerson. (2005) Regression to the mean: treatment effect without the intervention. Journal of Evaluation in Clinical Practice 11:10.1111/jep.2005.11.issue-1, 59-65
    CrossRef

  468. 468

    Marie D. Sauro, Roger P. Greenberg. (2005) Endogenous opiates and the placebo effect. Journal of Psychosomatic Research 58, 115-120
    CrossRef

  469. 469

    Alla Katsnelson. (2005) Researchers probe the real effect of placebos. Nature Medicine 11, 105-105
    CrossRef

  470. 470

    Andrew L. Geers, Paul E. Weiland, Kristin Kosbab, Sarah J. Landry, Suzanne G. Helfer. (2005) Goal Activation, Expectations, and the Placebo Effect.. Journal of Personality and Social Psychology 89, 143-159
    CrossRef

  471. 471

    Michael Ossege, Thomas Sycha, Martin Aigner, Leopold Schmetterer, Hans-Georg Eichler, Markus M??ller, Franz K??nig, Peter Bauer. (2005) Effect of Information on Reported Adverse Events in a Placebo-Controlled Trial. Drug Safety 28, 81-87
    CrossRef

  472. 472

    France Haour. (2005) Mechanisms of the Placebo Effect and of Conditioning. Neuroimmunomodulation 12, 195-200
    CrossRef

  473. 473

    Bernard Mazi??res. (2005) Topical Ketoprofen Patch. Drugs in R & D 6, 337-344
    CrossRef

  474. 474

    Nancy King Reame. (2005) The emerging science of hot flash relief: legitimizing the "obecalp" effect. Menopause 12, 4-7
    CrossRef

  475. 475

    Clara Singer, Iris Grossman, Nili Avidan, Jacques S Beckmann, Itsik Pe'er. (2005) Trick or treat: The effect of placebo on the power of pharmacogenetic association studies. Human Genomics 2, 28
    CrossRef

  476. 476

    Jim Young, Peter Tschudi, Pierre Périat, Christa Hugenschmidt, Antje Welge-Lüssen, Heiner C. Bucher. (2005) Patients’ Expectations about the Benefit of Antibiotic Treatment: Lessons from a Randomised Controlled Trial. Forschende Komplementärmedizin und Klassische Naturheilkunde / Research in Complementary and Classical Natural Medicine 12, 347-349
    CrossRef

  477. 477

    Bradley C. Johnston, Edward Mills. (2004) n -of-1 Randomized Controlled Trials: An Opportunity for Complementary and Alternative Medicine Evaluation. The Journal of Alternative and Complementary Medicine 10, 979-984
    CrossRef

  478. 478

    Diana Wyndham. (2004) Versemaking and lovemaking?W. B. Yeats' ?strange second puberty?: Norman Haire and the Steinach rejuvenation operation. Journal of the History of the Behavioral Sciences 39:10.1002/jhbs.v39:1, 25-50
    CrossRef

  479. 479

    Graeme Morgan, Robyn Ward, Michael Barton. (2004) The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clinical Oncology 16, 549-560
    CrossRef

  480. 480

    Nicholas Tarrier, Til Wykes. (2004) Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?. Behaviour Research and Therapy 42, 1377-1401
    CrossRef

  481. 481

    B.A. O'REILLY, P.L. DWYER, G. HAWTHORNE, S. CLEAVER, E. THOMAS, A. ROSAMILIA, M. FYNES. (2004) TRANSDERMAL POSTERIOR TIBIAL NERVE LASER THERAPY IS NOT EFFECTIVE IN WOMEN WITH INTERSTITIAL CYSTITIS. The Journal of Urology 172, 1880-1883
    CrossRef

  482. 482

    Richard Kradin. (2004) The placebo response complex. Journal of Analytical Psychology 49:10.1111/joap.2004.49.issue-5, 617-634
    CrossRef

  483. 483

    RM Douglas, H Hemilä, E Chalker, RRD D'Souza, B Treacy, Harri Hemilä. . Vitamin C for preventing and treating the common cold. 2004.
    CrossRef

  484. 484

    Reingard B.K. Rohrbock, Johann Hammer, Harald Vogelsang, Nicholas J. Talley, Heinz F. Hammer. (2004) Acupuncture has a Placebo Effect on Rectal Perception but not on Distensibility and Spatial Summation: A Study in Health and IBS. The American Journal of Gastroenterology 99:10.1111/ajg.2004.99.issue-10, 1990-1997
    CrossRef

  485. 485

    Harald Walach, Wayne B. Jonas. (2004) Placebo Research: The Evidence Base for Harnessing Self-Healing Capacities. The Journal of Alternative and Complementary Medicine 10, S-103-S-112
    CrossRef

  486. 486

    P. L. Hibberd, A. Patel, . (2004) Challenges in the Design of Antibiotic Equivalency Studies: The Multicenter Equivalency Study of Oral Amoxicillin versus Injectable Penicillin in Children Aged 3-59 Months with Severe Pneumonia. Clinical Infectious Diseases 39, 526-531
    CrossRef

  487. 487

    A. Hrobjartsson, P. C. Gotzsche. (2004) Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. Journal of Internal Medicine 256:10.1111/jim.2004.256.issue-2, 91-100
    CrossRef

  488. 488

    Michelle M. Haby, Rob Carter, Cathrine Mihalopoulos, Anne Magnus, Kristy Sanderson, Gavin Andrews, Theo Vos. (2004) Assessing Cost-Effectiveness - Mental Health: introduction to the study and methods. Australian and New Zealand Journal of Psychiatry 38:10.1111/anp.2004.38.issue-8, 569-578
    CrossRef

  489. 489

    E.A.M. Gale. (2004) The Hawthorne studies--a fable for our times?. QJM 97, 439-449
    CrossRef

  490. 490

    A Jon Stoessl, Raúl de la Fuente-Fernández. (2004) Willing oneself better on placebo—effective in its own right. The Lancet 364, 227-228
    CrossRef

  491. 491

    Ilker Yalcin, Richard C Bump. (2004) The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence. American Journal of Obstetrics and Gynecology 191, 194-197
    CrossRef

  492. 492

    Michael Carlston. (2004) Review of research in homeopathy: Theory and methodology. Seminars in Integrative Medicine 2, 72-81
    CrossRef

  493. 493

    Edward Gracely. (2004) The Role of Quasi-Experimental Designs in Pain Research. Pain Medicine 5, 146-147
    CrossRef

  494. 494

    Matthew D Lieberman, Johanna M Jarcho, Steve Berman, Bruce D Naliboff, Brandall Y Suyenobu, Mark Mandelkern, Emeran A Mayer. (2004) The neural correlates of placebo effects: a disruption account. NeuroImage 22, 447-455
    CrossRef

  495. 495

    Chinyu Su, Gary R. Lichtenstein, Karen Krok, Colleen M. Brensinger, James D. Lewis. (2004) A meta-analysis of the placebo rates of remission and response in clinical trials of active crohn’s disease. Gastroenterology 126, 1257-1269
    CrossRef

  496. 496

    Mark A Moyad, James H Barada, Tom F Lue, John P Mulhall, Irwin Goldstein, Ahmed Fawzy. (2004) Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I. Urologic Clinics of North America 31, 249-257
    CrossRef

  497. 497

    R Barker Bausell, Wen-Lin Lee, Karen L Soeken, Yu-Fang Li, Brian M Berman. (2004) Larger effect sizes were associated with higher quality ratings in complementary and alternative medicine randomized controlled trials. Journal of Clinical Epidemiology 57, 438-446
    CrossRef

  498. 498

    David T Yu, John Chae, Maria E Walker, Andrew Kirsteins, Elie P Elovic, Steven R Flanagan, Richard L Harvey, Richard D Zorowitz, Frederick S Frost, Julie H Grill, Michael Feldstein, Zi-Ping Fang. (2004) Intramuscular neuromuscular electric stimulation for poststroke shoulder pain: A multicenter randomized clinical trial 11A commercial party with a direct financial interests in the results of the research supporting this article has or will confer a benefit on the author or 1 or more of the authors. NeuroControl Corp, Valley View, OH, intends to commercialize the device evaluated in this article and has submitted a premarket 510(K)application, which is currently pending US Food and Drug Administration review. Chae and Feldstein are consultants to NeuroControl. Walker was an employee of NeuroControl, and is now a consultant to NeuroControl. Fang is an employee of NeuroControl. During this study, Yu served as a consultant to NeuroControl and Grill was an employee of NeuroControl, but neither now has an affiliation with NeuroControl.. Archives of Physical Medicine and Rehabilitation 85, 695-704
    CrossRef

  499. 499

    Asbjørn Hróbjartsson, Peter C Gøtzsche, Asbjørn Hróbjartsson. . Placebo interventions for all clinical conditions. 2004.
    CrossRef

  500. 500

    Olesen , Jes , Diener , Hans-Christoph , Husstedt , Ingo W. , Goadsby , Peter J. , Hall , David , Meier , Ulrich , Pollentier , Stephane , Lesko , Lynna M. , . (2004) Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine. New England Journal of Medicine 350:11, 1104-1110
    Free Full Text

  501. 501

    Nikola Biller-Andorno. (2004) The use of the placebo effect in clinical medicine — ethical blunder or ethical imperative?. Science and Engineering Ethics 10, 43-50
    CrossRef

  502. 502

    (2004) Another negative trial of manipulative treatment for back pain. Focus on Alternative and Complementary Therapies 9, 43-44
    CrossRef

  503. 503

    F. Bloch, G. Abitbol, B. Nouvel, P. Ferlender, A. Tellier, . (2004) Placebo et effet placebo dans la prise en charge de la douleur: sa perception par les soignants. Douleur et Analgésie 17, 25-32
    CrossRef

  504. 504

    Franz Porzsolt, Nicole Scholtz-Gorton, Nikola Biller-Andorno, Anke Thim, Karin Meissner, Irmgard Roeckl-Wiedmann, Barbara Herzberger, Renatus Ziegler, Wilhelm Gaus, Ernst Pöppel. (2004) Applying evidence to support ethical decisions: Is the placebo really powerless?. Science and Engineering Ethics 10, 119-132
    CrossRef

  505. 505

    Raúl de la Fuente-Fernández. (2004) Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease. Parkinsonism & Related Disorders 10, 125-127
    CrossRef

  506. 506

    Franklin G. Miller. (2004) Sham surgery: An ethical analysis. Science and Engineering Ethics 10, 157-166
    CrossRef

  507. 507

    Jacek Spławiński, Jerzy Kuźniar. (2004) Clinical trials: active control vs placebo — What is ethical?. Science and Engineering Ethics 10, 73-79
    CrossRef

  508. 508

    Berit Sverdrup. (2004) Use Less Cosmetics—Suffer Less from Fibromyalgia?. Journal of Women's Health 13, 187-194
    CrossRef

  509. 509

    Joan Box. (2004) Placebos and the UK medical research council — and the consumer perspective. Science and Engineering Ethics 10, 95-101
    CrossRef

  510. 510

    Lynn A Anderson, Jeffrey B Gross. (2004) Aromatherapy with peppermint, isopropyl alcohol, or placebo is equally effective in relieving postoperative nausea. Journal of PeriAnesthesia Nursing 19, 29-35
    CrossRef

  511. 511

    Claudio Sosa, Fernando Althabe, José M Belizán, Eduardo Bergel, Claudio Sosa. . Bed rest in singleton pregnancies for preventing preterm birth. 2004.
    CrossRef

  512. 512

    Josep M.a. Argimon Pallás, Josep Jiménez Villa. . Bases metodológicas de la investigación clínica y epidemiológica. 2004:, 8-15.
    CrossRef

  513. 513

    Steve Stewart-Williams, John Podd. (2004) The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate.. Psychological Bulletin 130, 324-340
    CrossRef

  514. 514

    Jordi Ferreres, Josep-Eladi Baños, Magí Farré. (2004) Efecto nocebo: la otra cara del placebo. Medicina Clínica 122, 511-516
    CrossRef

  515. 515

    Steve Stewart-Williams. (2004) The Placebo Puzzle: Putting Together the Pieces.. Health Psychology 23, 198-206
    CrossRef

  516. 516

    Ananias C Diokno. (2004) Medical management of urinary incontinence. Gastroenterology 126, S77-S81
    CrossRef

  517. 517

    Gunvor Bentung Lygre, Nils Roar Gjerdet, Lars Björkman. (2004) Patients' choice of dental treatment following examination at a specialty unit for adverse reactions to dental materials. Acta Odontologica Scandinavica 62, 258-263
    CrossRef

  518. 518

    James P. Rathmell, Daniel B. Carr. (2003) The Scientific Method, Evidence-Based Medicine, and Rational Use of Interventional Pain Treatments. Regional Anesthesia and Pain Medicine 28, 498-501
    CrossRef

  519. 519

    Douglas G Merrill. (2003) Hoffmanʼs Glasses. Regional Anesthesia and Pain Medicine 28, 547-560
    CrossRef

  520. 520

    Hans-Christoph Diener. (2003) Placebo in headache trials. Cephalalgia 23, 485-486
    CrossRef

  521. 521

    U Reuter, M Sanchez del Rio, JA Carpay, CJ Boes, SD Silberstein, . (2003) Placebo adverse events in headache trials: headache as an adverse event of placebo. Cephalalgia 23, 496-503
    CrossRef

  522. 522

    Richard Leigh, Glenda MacQueen, Gervais Tougas, Frederick E. Hargreave, John Bienenstock. (2003) Change in Forced Expiratory Volume in 1 Second After Sham Bronchoconstrictor in Suggestible but Not Suggestion-Resistant Asthmatic Subjects A Pilot Study. Psychosomatic Medicine 65, 791-795
    CrossRef

  523. 523

    Dr Pierre, Dr Michel. (2003) ‘Hyperbaric oxygen therapy and cerebral palsy’. Developmental Medicine & Child Neurology 45, 646-647
    CrossRef

  524. 524

    Asbjørn Hróbjartsson, Peter C Gøtzsche. (2003) Unreliable analysis of placebo analgesia in trials of placebo pain mechanisms. Pain 104, 714-715
    CrossRef

  525. 525

    D D. Price, L J. Riley, L Vase. (2003) Reliable differences in placebo effects between clinical analgesic trials and studies of placebo analgesia mechanisms. Pain 104, 715-716
    CrossRef

  526. 526

    Daniel B. Carr, Leonidas C. Goudas. (2003) Burning Questions, Randomized Controlled Trials, and the Pain Doctorʼs Dilemma. Regional Anesthesia and Pain Medicine 28, 360-361
    CrossRef

  527. 527

    Lynton G. F. Giles, Reinhold Muller. (2003) Chronic Spinal Pain. Spine 28, 1490-1502
    CrossRef

  528. 528

    Eric Leibing, Michael Pfingsten, Falk Leichsenring. (2003) Comment on: Molsberger AF, Mau J, Pawelec DB, Winkler J. Does acupuncture improve the orthopedic management of chronic low back pain? Pain 2002; 99:579–87. Pain 104, 425-426
    CrossRef

  529. 529

    John C. Licciardone, Scott T. Stoll, Kimberly G. Fulda, David P. Russo, Jeff Siu, William Winn, Jon Swift. (2003) Osteopathic Manipulative Treatment for Chronic Low Back Pain. Spine 28, 1355-1362
    CrossRef

  530. 530

    Alan Breen, Rosanna Breen. (2003) Back Pain and Satisfaction With Chiropractic Treatment: What Role Does the Physical Outcome Play?. The Clinical Journal of Pain 19, 263-268
    CrossRef

  531. 531

    A Eikermann, HC Diener. (2003) Effect of active treatment is lower when using placebo control in clinical trials on acute therapy of migraine. Cephalalgia 23, 344-347
    CrossRef

  532. 532

    Olof Ekre, Henrik Norrsell, Peter Wahrborg, Tore Eliasson, Clas Mannheimer. (2003) Coronary Artery Disease 14, 323-327
    CrossRef

  533. 533

    K Schmidt. (2003) The Science of the Placebo - Toward an Interdisciplinary Research Agenda. Focus on Alternative and Complementary Therapies 8, 279-280
    CrossRef

  534. 534

    K. MATTHEWS, M. S. ELJAMEL. (2003) Status of neurosurgery for mental disorder in Scotland: Selective literature review and overview of current clinical activity. The British Journal of Psychiatry 182, 404-411
    CrossRef

  535. 535

    Sam Horng, Franklin G. Miller. (2003) Ethical framework for the use of sham procedures in clinical trials. Critical Care Medicine 31, S126-S130
    CrossRef

  536. 536

    Lars Noah. (2003) Challenges in the Federal Regulation of Pain Management Technologies. The Journal of Law, Medicine & Ethics 31:10.1111/jlme.2003.31.issue-1, 55-74
    CrossRef

  537. 537

    Antonella Pollo, Sergio Vighetti, Innocenzo Rainero, Fabrizio Benedetti. (2003) Placebo analgesia and the heart. Pain 102, 125-133
    CrossRef

  538. 538

    Franklin G. Miller, David Wendler, Benjamin Wilfond. (2003) When do the federal regulations allow placebo-controlled trials in children?. The Journal of Pediatrics 142, 102-107
    CrossRef

  539. 539

    R. J. Temple. (2003) Implications of Effects in Placebo Groups. JNCI Journal of the National Cancer Institute 95, 2-3
    CrossRef

  540. 540

    W.Vaughn McCall, Ralph D'Agostino, Aaron Dunn. (2003) A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. Sleep Medicine 4, 57-62
    CrossRef

  541. 541

    G. Chvetzoff, I. F. Tannock. (2003) Placebo Effects in Oncology. JNCI Journal of the National Cancer Institute 95, 19-29
    CrossRef

  542. 542

    Gary N. Foulks. (2003) Challenges and Pitfalls in Clinical Trials of Treatments for Dry Eye. The Ocular Surface 1, 20-30
    CrossRef

  543. 543

    Paul A van den Dolder, David L Roberts. (2003) A trial into the effectiveness of soft tissue massage in the treatment of shoulder pain. Australian Journal of Physiotherapy 49, 183-188
    CrossRef

  544. 544

    P. Calverley, E.T. Keating, M. Goldman, F. Casty. (2003) Conclusion lessons from the novel D2 dopamine receptor, β2-adrenoceptor agonist, Viozan™: chronic obstructive pulmonary disease and drug development implications. Respiratory Medicine 97, S71-S74
    CrossRef

  545. 545

    Suzie Lavoie, Jean Paquet, Brahim Selmaoui, Marianne Rufiange, Marie Dumont. (2003) Vigilance Levels During and After Bright Light Exposure in the First Half of the Night. Chronobiology International 20, 1019-1038
    CrossRef

  546. 546

    H. Tsugeno, M. Mizuno, S. Fujiki, H. Okada, M. Okamoto, Y. Hosaki, S. Ashida, F. Mitsunobu, Y. Tanizaki, Y. Shiratori. (2003) A Proton-Pump Inhibitor, Rabeprazole, Improves Ventilatory Function in Patients with Asthma Associated with Gastroesophageal Reflux. Scandinavian Journal of Gastroenterology 38, 456-461
    CrossRef

  547. 547

    Jorge G Burneo, Victor M Montori, Edward Faught. (2002) Magnitude of the placebo effect in randomized trials of antiepileptic agents. Epilepsy & Behavior 3, 532-534
    CrossRef

  548. 548

    R. L. Bratton, D. P. Montero, K. S. Adams, M. A. Novas, T. C. McKay, L. J. Hall, J. G. Foust, M. B. Mueller, P. C. O'Brien, E. J. Atkinson, M. S. Maurer. (2002) Effect of 'Ionized' Wrist Bracelets on Musculoskeletal Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. Mayo Clinic Proceedings 77, 1164-1168
    CrossRef

  549. 549

    Don D. Sin, Irvin Mayers, Godfrey C.W. Man, Ali Ghahary, Lawrence Pawluk. (2002) Can Continuous Positive Airway Pressure Therapy Improve the General Health Status of Patients With Obstructive Sleep Apnea?. Chest 122, 1679-1685
    CrossRef

  550. 550

    A Hróbjartsson, PC Gøtzsche. . Placebo treatment versus no treatment. 2002.
    CrossRef

  551. 551

    Anne Moyer, John W. Finney. (2002) Outcomes for untreated individuals involved in randomized trials of alcohol treatment. Journal of Substance Abuse Treatment 23, 247-252
    CrossRef

  552. 552

    George F. Longstreth, Douglas A. Drossman. (2002) New developments in the diagnosis and treatment of irritable bowel syndrome. Current Gastroenterology Reports 4, 427-434
    CrossRef

  553. 553

    Lene Vase, Joseph L. Riley, Donald D. Price. (2002) A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99, 443-452
    CrossRef

  554. 554

    M. Robin DiMatteo, Patrick J. Giordani, Heidi S. Lepper, Thomas W. Croghan. (2002) Patient Adherence and Medical Treatment Outcomes. Medical Care 40, 794-811
    CrossRef

  555. 555

    Donald Moss, Jay Gunkelman. (2002) Task Force Report on Methodology and Empirically Supported Treatments: Introduction. Journal of Neurotherapy 6, 7-10
    CrossRef

  556. 556

    Eugene V. Boisaubin. (2002) Practitioners and Clinical Trials. True to Your Patients - or Science?. Journal of General Internal Medicine 17, 738-739
    CrossRef

  557. 557

    B. R. Levy, M. D. Slade, S. V. Kasl. (2002) Longitudinal Benefit of Positive Self-Perceptions of Aging on Functional Health. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 57, P409-P417
    CrossRef

  558. 558

    Ann M. Kosloske. (2002) Epidemiology as the Search for Truth. Seminars in Pediatric Surgery 11, 162-167
    CrossRef

  559. 559

    Robert M. Bennett. (2002) A survey of symptoms and treatment of fibromyalgia. Current Rheumatology Reports 4, 285-285
    CrossRef

  560. 560

    Philippe A. Lefere, Stefaan S. Gryspeerdt, Jef Dewyspelaere, Marc Baekelandt, Bartel G. Van Holsbeeck. (2002) Dietary Fecal Tagging as a Cleansing Method before CT Colonography: Initial Results—Polyp Detection and Patient Acceptance1. Radiology 224, 393-403
    CrossRef

  561. 561

    Moseley , J. Bruce , O'Malley , Kimberly , Petersen , Nancy J. , Menke , Terri J. , Brody , Baruch A. , Kuykendall , David H. , Hollingsworth , John C. , Ashton , Carol M. , Wray , Nelda P. , . (2002) A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee. New England Journal of Medicine 347:2, 81-88
    Free Full Text

  562. 562

    Horng , Sam , Miller , Franklin G. , . (2002) Is Placebo Surgery Unethical?. New England Journal of Medicine 347:2, 137-139
    Full Text

  563. 563

    Steven F. Moss, Irvin M. Modlin. (2002) Irritable Bowel and the Irritable Physician. Journal of Clinical Gastroenterology 35, S68-S70
    CrossRef

  564. 564

    (2002) The Management of Persistent Pain in Older Persons. Journal of the American Geriatrics Society 50, 205-224
    CrossRef

  565. 565

    MURAD ALAM, NAYOMI E. OMURA, JEFFREY S. DOVER, KENNETH A. ARNDT. (2002) Glycolic Acid Peels Compared to Microdermabrasion. Dermatologic Surgery 28, 475-479
    CrossRef

  566. 566

    Raúl de la Fuente-Fernández, Michael Schulzer, A Jon Stoessl. (2002) The placebo effect in neurological disorders. The Lancet Neurology 1, 85-91
    CrossRef

  567. 567

    Murad Alam, Nayomi E. Omura, Jeffrey S. Dover, Kenneth A. Arndt. (2002) Glycolic Acid Peels Compared to Microdermabrasion: A Right-Left Controlled Trial of Efficacy and Patient Satisfaction. Dermatologic Surgery 28, 475-479
    CrossRef

  568. 568

    Asbjørn Hróbjartsson. (2002) What are the main methodological problems in the estimation of placebo effects?. Journal of Clinical Epidemiology 55, 430-435
    CrossRef

  569. 569

    Alvan R. Feinstein. (2002) Post-Therapeutic Response and Therapeutic ‘Style’. Journal of Clinical Epidemiology 55, 427-429
    CrossRef

  570. 570

    Peter S. Staats. (2002) Implications of the Placebo Response for Interventional Pain Specialists. Neuromodulation: Technology at the Neural Interface 5, 69-71
    CrossRef

  571. 571

    Caroline Smith, Caroline Crowther, Justin Beilby. (2002) Acupuncture To Treat Nausea and Vomiting in Early Pregnancy: A Randomized Controlled Trial. Birth 29, 1-9
    CrossRef

  572. 572

    Alan B. Kochman, Dale H. Carnegie, Thomas J. Burke. (2002) Symptomatic Reversal of Peripheral Neuropathy in Patients with Diabetes. Journal of the American Podiatric Medical Association 92, 125-130
    CrossRef

  573. 573

    Peter A. Clark. (2002) Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?. The Journal of Law, Medicine & Ethics 30:10.1111/jlme.2002.30.issue-1, 58-68
    CrossRef

  574. 574

    P. J. M. M. Toll, C. M. Corbey. (2002) Hoe werkzaam is een placebo?. Medisch-Farmaceutische Mededelingen 40, 29-30
    CrossRef

  575. 575

    Mark A Moyad. (2002) Dietary supplements and other alternative medicines for erectile dysfunction What do I tell my patients?. Urologic Clinics of North America 29, 11-22
    CrossRef

  576. 576

    Cheryl Hawk, Cynthia R. Long, Robert Reiter, Charles S. Davis, Jerrilyn A. Cambron, Roni Evans. (2002) Issues in Planning a Placebo-Controlled Trial of Manual Methods: Results of a Pilot Study. The Journal of Alternative and Complementary Medicine 8, 21-32
    CrossRef

  577. 577

    Mark A Moyad. (2002) The placebo effect and randomized trials: analysis of conventional medicine. Urologic Clinics of North America 29, 125-133
    CrossRef

  578. 578

    William E. Pelham, Betsy Hoza, David R. Pillow, Elizabeth M. Gnagy, Heidi L. Kipp, Andrew R. Greiner, Daniel A. Waschbusch, Sarah T. Trane, Joel Greenhouse, Lara Wolfson, Erin Fitzpatrick. (2002) Effects of methyphenidate and expectancy on children with ADHD: Behavior, academic performance, and attributions in a summer treatment program and regular classroom settings.. Journal of Consulting and Clinical Psychology 70, 320-335
    CrossRef

  579. 579

    Eugene M. Laska, Paul Leber. (2002) If Placebo Works, Could, Should or Would it be Approved for Marketing?. CHANCE 15:2, 22
    CrossRef

  580. 580

    Stephen Senn. (2002) The Unpleasant Placebo?. CHANCE 15:2, 27
    CrossRef

  581. 581

    (2001) LiteratureWatch. Alternative and Complementary Therapies 7, 391-392
    CrossRef

  582. 582

    Yiannis G. Papakostas, Michael D. Daras. (2001) Placebos, Placebo Effect, and the Response to the Healing Situation: The Evolution of a Concept. Epilepsia 42, 1614-1625
    CrossRef

  583. 583

    STEPHEN D. SIMON. (2001) Is the Randomized Clinical Trial the Gold Standard of Research?. Journal of Andrology 22:10.1002/jand.2001.22.issue-6, 938-943
    CrossRef

  584. 584

    (2001) Is the Placebo Powerless?. New England Journal of Medicine 345:17, 1276-1279
    Free Full Text

  585. 585

    José Luis Rodriguez-Martin, José Manuel Barbanoj, TE Schlaepfer, Susana SC Clos, V Pérez, J Kulisevsky, A Gironelli, José Luis Rodriguez-Martin. . Transcranial magnetic stimulation for treating depression. 2001.
    CrossRef

  586. 586

    Michelle M. Garrison, Dimitri A. Christakis. (2001) Infant Colic. Pediatric Case Reviews 1, 19-24
    CrossRef

  587. 587

    Emanuel , Ezekiel J. , Miller , Franklin G. , . (2001) The Ethics of Placebo-Controlled Trials — A Middle Ground. New England Journal of Medicine 345:12, 915-919
    Full Text

  588. 588

    David P.J. Osborn. (2001) Placebos and research ethics: an absolute dilemma?. Current Opinion in Psychiatry 14, 507-511
    CrossRef

  589. 589

    John Z. Sadler, Bill Fulford. (2001) Editors’ introduction: on becoming and constraining science. Current Opinion in Psychiatry 14, 483-484
    CrossRef

  590. 590

    Arthur P. Grollman. (2001) Need for Scholarly, Objective Inquiry into Alternative Therapies. Academic Medicine 76, 864-865
    CrossRef

  591. 591

    Stefan Wöhrl, Wolfgang Hemmer. (2001) Placebos and pain management. The Lancet 358, 1101-1102
    CrossRef

  592. 592

    Helen Pearson. (2001) Great expectations. news@nature
    CrossRef

  593. 593

    David J Rowbotham. (2001) Endogenous opioids, placebo response, and pain. The Lancet 357, 1901-1902
    CrossRef

  594. 594

    Bailar , John C. III , . (2001) The Powerful Placebo and the Wizard of Oz. New England Journal of Medicine 344:21, 1630-1632
    Full Text

  595. 595

    Wang Bao-en. (2001) Ademetionine 1,4 Butanedisulphonate vs Traditional Chinese Medicine for the Treatment of Hepatocellular Jaundice Complicating Chronic Viral Hepatitis. Clinical Drug Investigation 21, 765-773
    CrossRef

  596. 596

    Anup Malani, Daniel Houser. . Expectations mediate objective physiological placebo effects. :, 311-327.
    CrossRef

Trends

Most Viewed (Last Week)